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                                                                         ABSTRACT 
INTRODUCTION 
             Gastric cancer is the second most common type of cancer   world  wide.  Of  the  gastric  cancer,  
adenocarcinoma  is  the  most  common malignancy. It  comprises  over  90%  of  all  gastric  cancers. 
Gastric  mucins   are   cytoprotective  proteins  synthesized  by gastric epithelial cells. In general mucins are  
of two types,  neutral and acid mucin.  Mucin   genes  expression  in normal  stomach  includes  MUC1 , 
MUC  5AC  in  surface epithelium,  MUC 6  in  deep  gastric  glands.  MUC 2 is   not  expressed  in  normal  
stomach. MUC 2  is  expressed  in  intestinal  metaplasia  by  goblet cells,  intestinal  type  of  gastric 
adenocarcinoma  and  mucinous  gastric  adenocarcinoma. MUC 2 expression  is  decreased  in  poorly  
differentiated  gastric   adenocarcinoma and  variable in  signet  ring  cell  carcinoma  of  stomach 
AIM :  To  study the role of  mucin  histochemistry and immunohistochemistry  in gastric adenocarcinoma 
MATERIALS  AND  METHODS 
          From  the  period 2008 oct – 2011 sep, 50  cases  of  gastrectomy  specimens  were  analysed  
Age, sex and   site  of  the  lesion  were  recorded. Subtyping  of  carcinoma  was  done. Mucin  type   
neutral / acidic  is identified  by  AB pH 2.5  PAS  and  PAS  staining. Immunohistochemistry   using  
MUC2  primary  antibody   was  done  to  assess  the  role  of  its  expression  in  various  types  of  gastric  
adenocarcinoma. Results  were  tabulated  and  analysed. 
RESULTS 
       Incidence  of  gastric cancer  among  the  malignancies  during the  period 2008 oct – 2011 sep is  4.4%  
 in  male  – 58%  and in female - 42%. Male  predominate  in  the  ratio  of 3:2 with male  peak  incidence in 
the 6
th
 decade  and female  peak  incidence in  the 5
th
  decade. Mean age of  gastric cancer – 56.7yrs(25-80). 
 Incidence  of  early  gastric  cancer  is  2% with commonest  site -  antropyloric  region  86%.Intestinal type 
predominates  by  61.2%. Incidence  of signet ring cell carcinoma – 2%. On  mucin  histochemistry, acid 
mucin  is  demonstrated in  96 % of   gastric  cancer. Acid  mucin  is  expressed  more  in poorly  
differentiated  and  mucinous  adenocarcinoma  type  of  gastric  cancer. On  immunohistochemistry, MUC 2 
expression  is  more in  intestinal metaplasia,   >50%  in  mucinous  adenocarcinoma,  >10%  in signet  ring  
cell  carcinoma, absent  in  intestinal type  of  gastric  adenocarcinoma and  poorly  differentiated  
adenocarcinoma.  AE1/AE3  showed   diffuse  and  strong cytoplasmic  positivity  in  squamous  cell 
carcinoma. 
KEYWORDS  
Gastric adenocarcinoma,  special stain,  MUC 2 expression 
 
                                         INTRODUCTION 
              Gastric cancer is the second most common type of cancer   world  wide.  It is one 
of   the  leading cause of death  in the world. The highest incidence of gastric cancer is in Asia
59
,Central 
Europe and south America   >40/1,00,000. The lower rates are in   North  America,Northern  Europe, 
most countries in Africa and  south eastern Asia  <15/1,00,000
58
. 
            In India, it is around   8.9/1,00,000. Thus  the  incidence  of gastric carcinoma  varies  from  
place to  place  due  to  environmental  factors, dietary and host related factors
81
. 
            Of  the  gastric  cancer,  adenocarcinoma  is  the  most  common malignancy. It  comprises  over  
90%  of  all  gastric  cancers. Gastric  carcinoma  is  more  common  in  low  socioeconomic   groups  and  
in  individuals  with   multifocal  mucosal  atrophy  and intestinal  metaplasia. 
          The  overall  incidence  of   gastric  adenocarcinoma  is  decreased  world  wide  but  the  
cancer  of  cardia  is  on  the  rise
56
. 
          Gastric  mucins   are   cytoprotective  proteins  synthesized  by gastric epithelial cells. In 
general mucins are  of two types,  neutral and acid mucin. Normal gastric mucin is neutral mucin.  
There is transition  from  neutral   mucin to  acid  mucin   when  there  is  neoplastic  transformation. 
         Mucin   genes  expression  in normal   stomach  includes  MUC1 ,MUC 5AC  in  surface 
epithelium,  MUC 6  in  deep  gastric  glands.  MUC 2 is   not  expressed  in  normal  stomach. 
MUC 2  is  expressed  in  intestinal  metaplasia  by  goblet cells,  intestinal  type  of  gastric 
adenocarcinoma  and  mucinous  gastric  adenocarcinoma
73
. 
         MUC 2   expression  is  decreased  in  poorly  differentiated  gastric   adenocarcinoma 
and   signet  ring  cell  carcinoma  of  stomach.  MUC 2 expressing goblet cells   are  stained by 
Alcian  blue  pH  2.5. 
67
 
               This   prospective  study  of  gastrectomy  cases   was done  with  special   reference  to  
mucin  expression  in  various  types of gastric  adenocarcinoma. The patient details were 
collected and  histopathological  evaluation of gastrectomy specimens  were  done  with  routine 
H & E stain   and  special stains  to demonstrate  the  nature  of mucin expressed in it.   
                In  semiurban  area like Thanjavur, the life style and nutrition  factor  proves to be 
vital  in the  occurrence of  gastric carcinoma.  In  this  study , the histopathological  features  of 
gastric  adenocarcinoma  was described in detail  paying particular attention to the expression of 
mucin. The  mucin  profile in  gastric  adenocarcinoma  was  studied  by  mucin histochemistry  
with  PAS ,  Alcian  blue  pH 2.5 PAS   staining  and  with  immunohistochemistry    by  MUC 2  
(Leica , USA)   expression. The  cases  include   mucinous  adenocarcinoma ,  signet  ring  cell  
carcinoma  and  well differentiated,  moderately  differentiated,  poorly  differentiated  
adenocarcinoma  along  with  areas  of   intestinal  metaplasia. 
               Recent  studies  and  literature  proved  that  MUC   gene  expression  in  gastric  
adenocarcinoma  and  its  precursors  serve  as  diagnostic  and  prognostic  marker.  
              A  case  of  squamous  cell  carcinoma  in  the  cardiac  region  of  stomach was  studied   
with  AE1/AE3 expression  by  immunohistochemistry.   
              This  study  is  undertaken  in  view of  evaluating  the  actual  incidence  of  gastric 
carcinoma  in semiurban  area  like  Thanjavur  with  particular  attention  to  mucin  expression. 
In addition the recent literatures,  journals  and  research  publications regarding  gastric  cancer  
were also  immensely reviewed.   
 
                                                   
 
                                       
 
                                      AIMS AND OBJECTIVES 
  
Gastrectomy  and  endoscopic  biopsies  of  stomach  were  studied  to  find  out   
1. Incidence  of  gastric  adenocarcinoma  in  relation  to  age  and  sex 
2. Site  of occurrence  (cardia , body ,  antrum)   
3. Role  of  mucin  histochemistry  in  various  types  of  gastric  adenocarcinoma   by 
       Alcian  blue  pH 2.5 PAS  and  PAS.  
4. Expression  of  MUC 2 , a  mucin  protein  studied by  immunohistochemistry  on  
normal   stomach mucosa , intestinal  metaplasia  and   various types of 
gastric  adenocarcinoma. 
      5.  To  analyse  mucin   association  with  respect  to  subtypes  based  on  degree  of   
            differentiation of gastric adenocarcinoma 
      6.  To  analyse  the  prognosis   of  various  types  of  gastric  adenocarcinoma  by  
            MUC 2  expression.   
 
 
 
                                                                                                                                                                      
  
 
 
                                                   
                                    MATERIALS   AND   METHODS 
               A  total of  303  endoscopic  biopsies  of  stomach  and  50  gastrectomy  specimens  
including  total  and  partial  gastrectomy  were  received  for  examination  in   the  Department 
of   Pathology, Thanjavur  medical  college  from    medical  and  surgical  gastroenterology   
department  from  2008 October  to  2011 September were  included  in  this  study. 
              For  all  the  cases,  details  of  age  and  sex  were  recorded. Depending  on  the  site  of  
growth,  stomach  was  opened  through the  greater or lesser  curvature. The specimen is pinned out on 
a wax board with mucosal side up and fixed in 10% buffered formalin overnight. The specimen is 
measured including the length of greater and lesser curvature. The location, shape, maximal dimension 
of the tumor   and its distance to margins are recorded. Any other gross  abnormalities  of  gastric 
mucosa  also be recorded. The   grossly identified tumor  is then cross sectioned  to examine the depth 
of invasion.    
SECTIONS  FOR  HISTOLOGY
1
 INCLUDE 
1. Tumor -  four  sections  through  wall, including tumor border  and adjacent mucosa 
2. Non  neoplastic  mucosa, mid stomach , two sections 
3. Proximal  line of  resection  along lesser  curvature, two sections 
4. Proximal  line  of  resection  along  greater curvature , two sections 
5. Distal line  of  resection (along pylorus and duodenum, if  present), two sections 
6. Spleen  , if  present 
7. Pancreas , if present 
8. Lymph nodes:   
a. Pyloric,  Lesser curvature , Greater curvature 
b. Omentum, Perisplenic 
            Bits   were  processed  routinely  for  paraffin   embedding. Multiple  thin  sections of  3-5µ   
 thickness  were  cut  from  paraffin  blocks  and  stained  with  routine  H& E stain.(Appendix I) 
           Blocks  that  had  areas  of  intestinal  metaplasia  and   frank  malignancy  were  taken  and   
stained   with  special  stains  such  as  PAS (Appendix III)  and  Alcian Blue  pH 2.5 PAS (Appendix 
II). A  subjective  assessment of  relative  proportion  of  acidic  and  neutral  mucin   was  made  for  
each  tumor  by  Alcian  Blue  pH 2.5 PAS.  Samples  of  appendix  and  colonic  mucosa   were  taken  
as  control  for  PAS  and  AB pH 2 .5 PAS  respectively. 
         Blocks  of  signet  ring  cell carcinoma,   mucinous  adenocarcinoma and  well differentiated 
adenocarcinoma, moderately  differentiated,  poorly  differentiated  adenocarcinoma    along  with 
areas  of  intestinal  metaplasia  were  taken  and  studied    for  MUC 2   expression by   
immunohistochemistry (Appendix IV) . Expression   of  AE1/AE3  in  squamous  cell  carcinoma   of  
stomach  was   also  studied. 
 
   
 
 
 
                              
                                                 
 
 
                                        REVIEW OF LITERATURE 
                Gastric  cancer  is  a  leading  cause  of  death  in  the  world  inspite  of  a  trend  
 of decreasing  incidence  in  most  countries. Gastric  adenocarcinoma  has  high  mortality  rate  with  
5yrs  survival  rate  of   approximately  20%.
65
 One  of  the  main  survival  limiting  factor  is  late   
detection  of  tumor. 
ANATOMY
80 
             Stomach  is  a  distensible bag  with  a  variable  size  located  a  few  centimeter 
 below   the  diaphragm. By  convention it  is  divided  into  5 regions. The   cardia  is  an  illdefined 
area  that  connects   the  gastroesophageal  junction. The  fundus  is  the  superior  
portion   of  the  stomach  above  GE  junction. The   body  or  corpus  is  the  main  portion  of  
the  stomach  below  the  fundus. The  antrum  is  the   distal  portion  separated  from  the 
body  approximately   at  the  incisura  angularis. Finally , the  pylorus  is  a 1-2 cm  narrow  channel  
that  extends  from  the  antrum  and  connects   the  stomach  to  the  duodenum. 
               Stomach  is  a complex  organ  particularly in  its  epithelial  components . Its  mucosa  
is divided  into fundic  and  antral  type. Fundic  type  mucosa  is  present  in  fundus  and  body. 
It  consists  of   fundic  or  oxyntic  glands  occupying  approximately  80%  of  the  mucosal   
thickness.  The  superficial [20%]  consists  of  foveolar  cells  that  are  tall, columnar and  produce 
neutral  mucin. The  fundic  glands  contain  acid  secreting [parietal  cells]  and  zymogenic cells 
[chief  cells]. 
            The  antral  type  mucosa  is  seen  in  antrum, pylorus  and  cardia   where  the  deeper   
glands are  loosely  packed  and  mucin producing. In  antral  type  mucosa,  the  ratio  of  mucinous 
glands  to  overlying  foveolae  is  roughly 1:1. The  lamina  propria   of  the  stomach  contains 
only  a  minimal  number  of  lymphocytes, plasma  cells, eosinophils  and  mast  cells.  
            The   submucosa  consists  of  loose  connective  tissue  with  numerous  elastic  fibres. It   
contains  arteries,  veins  ,lymph  vessels  and  Meissner’s  nerve  plexus. The  muscuaris  propria  and    
serosa  of  the  stomach  are  histologically   similar   to  those  of  stomach. The  muscularis   
propria  is  formed  of  inner  circular  and  outer  longitudinal layer. 
EPIDEMIOLOGY
80 
             Gastric  cancer  incidence  varies  with  geography. In  Japan, Chile, Coast Rica  and Eastern  
Europe the  incidence  is  upto  20  fold  higher  than  in North America, Northern  Europe, Africa 
and  South east  Asia. Due  to  mass  endoscopic screening  program in the high   incidence  region 
such   as  Japan, 35%  of  newly  detected  cases  were  early  gastric  cancer  ie;  tumor  limited  to 
mucosa  and  submucosa. 
            In  United states ,the  incidence was  reduced  to 85% in  the 20
th
  century.  Gastric   
adenocarcinoma  was  the  commonest  cause  of  cancer  death  during  1930s and  remains  a 
leading  cause  of  cancer death  world wide. Now  it  accounts  for  fewer  than  2.5%  of  cancer   
deaths  in  the  United  states. Similar  declines  have  been  reported  in  many  other  Western  
countries,  suggesting  that  environmental  and  dietary  factors  are  responsible. 
            Even though the  overall  incidence  of  gastric  cancer  is reduced,  cancer  of  gastric  cardia   
is  on  the  rise. It  is  due  to  Barrett’s   esophagus, chronic  gastric  esophageal  reflux  disease  and   
obesity due  to  common  pathogenesis, esophageal  adenocarcinoma  and gastric  cardia   
adenocarcinoma  are  similar  in  morphology,  clinical  behavior  and   therapeutic  response.  
AGE  AND  SEX  DISTRIBUTION
54 
            Gastric  carcinoma  is  extremely  rare  below  the  age  of  40. It  increases  thereafter  to   
reach  highest  rate  in  the  oldest  age  group  both  in  male  and  female. The  intestinal type  
rises  faster  than  the  diffuse  type  which  is  more  common  in  males  than  in  females.  
Diffuse  type  affects  younger  individuals  mainly  females and  has  poor  prognosis.                 
AETIOLOGY
54 
          HIGH RISK – low  socioeconomic  status,   salt  intake, smoked  meat  or  fish, pickled   
 vegetables, chilli , peppers, soyabeans, host factor – H.pylori  infection 
HIGH RISK EXPLANATION 
        The  diets  mentioned  above  have  low level  of  micronutrients , vitamins  and   
antioxidants   which favors   intraluminal  formation  of  genotoxic  agents  such  as  specific  
 N – nitrosocompounds that  leads to gastric carcinoma  
  H.pylori 
            Long   standing  infection  by  H.pylori  leads  to  chronic  gastritis,  atrophic  gastritis   
and   intestinal  metaplasia   which  is  associated  with  increased  risk  of   intestinal  type                                                                 
of  gastric adenocarcinoma.   
          Incidence  of  gastric adenocarcinoma  of  diffuse type  is  higher  in  blood  group  A, in  people  
having  family  history  of  gastric carcinoma  or  pernicious  anemia.  
 LOWEST  RISK 
         Fresh   fruits,  vegetables,  ascorbic  acid,  carotenoids,  folates  and  tocopherols 
YOUNG  AGE  
          In  contrast  to  intestinal  type,  diffuse  type  is  more  common  in  young  age  with 
 equal   incidence  in  both  high  risk  and  low  risk  geographic  areas  due  to  regulation  by   
genetic  factors 
 
 
 
PATHOGENESIS
65 
           While  majority  of  gastric  cancers  are  not  hereditary, the  mutation  identified  in familial 
gastric  cancer  has  provided  important  insights  into  the  mechanism  of  carcinogenesis  in sporadic  
cases, germline  mutations  in  CDH1, which  encodes  E – cadherin, a protein  that  contributes  to  
epithelial  intercellular  adhesion. It  is  usually  associated  with  familial  gastric cancer  which  is  
usually  of  diffuse  type.  Mutation  in  CDH1   are  usually  present  in  about 50%  of  sporadic  cases  
of  diffuse  gastric  cancer. E- cadherin  expression  is  decreased  in the rest often  by  methylation  of   
the  CDH1  promoter. Thus   the  loss  of  E – cadherin  function seems to  be  a key   step in  the   
development  of   diffuse   gastric  cancer. Individuals  with  BRCA 2   mutations  are  at  increased  
risk  of  developing    diffuse  gastric  cancer. 
         In  intestinal  type  of  gastric  cancer, there  is  mutation  of   β catenin, a protein  that  binds 
to   both  E cadherin  and  APC. There  is  also  microsatellite  instability  and  hypermethylation  of 
several  genes  including  TGFβRII, BAX, IGFRII  and  INK 4a/p16  in  sporadic  intest inal  type of  
gastric  cancer. 
         Genetic  variants  of  proinflammatory  and  immune  response ,  including  those that  encode IL -
1β, TNF, IL – 10, IL -8  and  TLR 4 [Toll   like  receptors 4 ] are  associated  with  increased  risk of  
gastric  cancer  when  accompanied  by  H.pylori  infection  and p53  mutation  is   present  in  majority   
of  sporadic  gatric  cancer  of  both  histologic  types. Thus  chronic  inflammation  promotes  gastric  
cancer.      
 
 
 
 
LOCALISATION 
          Most  common  site  is  distal  stomach  in  antropyloric  region  and  along  the lesser  
curvature , recently  the  incidence Is  more  common  in  cardiac  region  of  stomach. Carcinoma  in 
the  corpus  is  located  along the  greater  curvature  or  lesser  curvature.  Early  cancer  occur   
commonly  in  middle  part  of  stomach   along   the  lesser  curvature.   Advanced  cancer occur  more 
commonly  in  antral   region  followed  by   corpus  region. 
 CLINICAL  FEATURES 
          Early  cancer  is  usually  asymptomatic,  50%  present  with  dyspepsia.  In  advanced  
cancer  patient  present  with  abdominal  pain  which  is  not  relieved  by  food,  if  ulcerated 
there  will be  hemetemesis .If  the  tumor  obstruct  the  gastric  outlet, there  will  be 
vomiting.  Systemic  symptoms such  as  anorexia,  weight  loss  suggest  disseminated  disease 
PRECURSORS
54 
          The  precursors  of  gastric  cancer  have  been  separated  into  2  major  categories 
1. Precancerous  conditions – clinical  condition with  increased  risk  of  gastric  cancer 
2. Precancerous  lesions -  pathological  changes  from  which  gastric  carcinoma  
       eventually  evolves .   
   It  is believed  that  precancerous  condition  is  preceded  by  the  occurance  of  
 precancerous  lesion. 
PRECANCEROUS  CONDITIONS 
         Epithelial  polyp 
         Chronic  atrophic  gastritis  - more  common  condition  leads  to  carcinoma 
         Intestinal  metaplasia 
         Chronic  ulcer 
         Gastric  remnants  
         Hyperplastic  gastropathy 
INTESTINAL  METAPLASIA 
         The  gastric  mucosa  is  transformed  into  intestinal  type  mucosa  with  complex  and   
heterogenous  features. 
          Intestinal  metaplasia  begins  in  the  neck  region  which  is  the  proliferative  zone 
of  normal   gastric  glands and  first  appears  at  antral  corpus  junction. 
          Charles M  leys  et  al  studied  that  two  types  of  metaplasia  is  associated  with  gastric   
cancer,  namely  intestinal  metaplasia  and antralization  of  gastric  fundus.  
CLASSIFICATION  OF  INTESTINAL  METAPLASIA 
          Based  on  cell  type  and  their  functional  features 
1. complete  intestinal  metaplasia 
                   Gastric  mucosa  assumes  appearance  of  small  intestine  without  villi.  Glands  are  
lined   by  absorptive  cells,   goblet  cells, paneth  cells  and  endocrine  cells. Mucin  can  be  
sulfomucin, sialomucin  or  both. 
2. Incomplete  intestinal  metaplasia                  
                   Instead  of  absorptive  cells,  columnar  cells  between  the  goblet  cells  resemble   
foveolar  mucous  cells.  Mucin  can  be  neutral,  sialomucin  or  sulfomucin. 
JASS  AND  FILIPE  CLASSIFICATION 
      Based  on  presence  of  absorptive  cells  in  complete  type  and  mucus  secreting  columnar  
cells  in  incomplete  type      
             
 
TYPE I – complete  intestinal  metaplasia 
TYPE II – incomplete  type ,  Type II A – nonsulphated  mucin 
                                                 Type  II B  - Sulfated  mucin 
TYPE  II  -   more  prone  for  precancerous  situations  and  gastric  adenocarcinoma. 
  RECENT   CLASSIFICATION
54 
         TYPE  I  - complete  intestinal  metaplasia 
        TYPE  II  - incomplete  intestinal metaplasia  [old  type II A] 
        TYPE  III  - incomplete  intestinal  metapasia  with  predominant   
                           sulfated  mucin [old  type  IIB]  
PRECANCEROUS   LESIONS 
          Adenoma  with  dysplastic  cells  is the  most  common  condition. Dysplasia  is  closely   
associated  with  expanding  or  intestinal  type  of  gastric  cancer    
 INTRA EPITHELIAL  NEOPLASIA 
         Intraepithelial  neoplasia  or  dysplasia  arises  in  either  the  native  gastric  or of  
intestinalized  gastric  epithelia. Pyloric  gland  adenoma  is  a  form of  intraepithelial   
neoplasia  arising in  the  native  mucosa. In  the  multistage  theory  of  gastric  oncogenesis,  
intraepithelial noeplasia  lies  between  atrophic  metaplastic  lesions  and  invasive  cancer. 
It  has  to be  differentiated  from  reactive/regenerative  changes  associated  with  inflammation 
and  invasive  carcinoma. several  proposals  have  been  made  for  terminology  of  the  morpholo 
gical  spectrum  of  lesions  that  lies  between  non neoplastic changes  and  early  invasive cancer, 
including  international  Padova  classification. 
 
 
INDEFINITE  FOR  INTRAEPITHELIAL  NEOPLASIA 
         Cases  lacking  all  the   features for  definitive  diagnosis  of  intraepithelial neoplasia may be 
placed  in this  category. In  native  gastric  mucosa, foveolar  hyperplasia may  be  indefinite  for 
dysplasia ,showing  irregular  and  tortuous  tubular  structures with  epithelial  mucus  depletion, high  
nuclear- cytoplasmic  ratio and  loss of  cellular  polarity. Large , oval/round, hyperchromatic nuclei  
associated  with  prominent  mitosis are  usually  located  near  proliferative  zone  in  the mucus   neck  
region. In  intestinal  metaplasia, areas  indefinite  for  intraepithelial  neoplasia  exhibit  a 
hyperproliferative metaplastic  epithelium. The glands  may  appear  closely  packed, lined  by cells  
with  large , hyperchromatic rounded or elongated, basally  located nuclei. Nucleoli  are  an inconstitent  
finding. The cytoarchitectural  alteration  tend to  decrease  from  the  base  of  the  glands to their  
superficial  portion. 
INTRAEPITHELIAL  NEOPLASIA 
       It  has  flat,  polypoid  or  slightly  depressed  growth  pattern. In  Western  countries,   
the  term  adenoma is  applied  for  discrete, protruding  lesion. In  Japan, adenoma include  all 
gross  types  such  as  flat, elevated and  depressed. Gasric  adenoma  are  less  common  than 
hyperplastic  polyp and  accounts  for about  10%  of polyps. They  arise in the antrum/mid  stomach   
and  in  areas  of  intestinal  metaplasia. 
LOW  GRADE  INTRAEPITHELIAL  NEOPLASIA 
       It  shows  tubular structures  with  budding and  branching, papillary infolding, crypt   
lengthening  with  serration  and  cystic  changes . Glands  are  lined  by  enlarged  columnar  cells,                                                                
with  minimal  or  no  mucin. Homogenously  blue  vesicular, rounded/ ovoid nuclei  are  usually 
pseudostratified  in  the proliferation  zone located  at  the  superficial  portion  of  the  dysplastic   
epithelium. 
HIGH  GRADE  INTRAEPITHELIAL  NEOPLASIA 
        There  is  increasing  architectural  distortion  with  glandular  crowding  and  prominent  
 cellular  atypia. Tubules  can  be  irregular  in  shape  with  frequent branching  and  folding. 
There is   no stromal  invasion. Mucin  secretion  is  minimal  or  absent. The  pleomorphic, 
hyperchromatic, usually   pseudostratified  nuclei  often are  cigar  shaped. Prominent  amphophilic 
nucleoli  are  common. Increased  proliferative  activity  is  present  through out  the  epithelium. 
PROGRESSION  OF  INTRAEPITHELIAL  NEOPLASIA  TO  CARCINOMA
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        Carcinoma  is  diagnosed  when  the  tumor  invades  into  the  lamina  propria (intramucosal  
carcinoma) or  through  the muscularis  mucosa.  Upto  80% of  intraepithelial  neoplasia 
may  progress to  invasion          
CORREA  CASCADE  of  multistep  carcinogenesis
56
  
          The  development  of  gastric  adenocarcinoma  represents  the  involvement  of   
                                                   Inflammation 
                                                                                                                   
                                            Intestinal   metaplasia 
                                                               
                                                       Dysplasia  
 
                                                     
                                                  Gastric  cancer 
                                                          
 
 
CLASSIFICATION  OF  GASTRIC  ADENOCARCINOMA
54 
          Gastric  carcinoma  is  classified  according  to  their  site  , gross  and  histomorphology. 
Based  on  invasiveness   - 2 types  
I.    Early  gastric  cancer   
Invasive  adenocarcinoma  of  stomach  confined  to  the  mucosa  or   submucosa 
   regardless  of  lymphnode  metastasis. 
          This  type  has  male  predominance, occurs  in  >50  yrs  of  age, usually  asymptomatic 
    or  present  with  epigastric  pain,  dyspepsia. Present  as  small  mass  measuring  around   
     2 – 5 cm  on  lesser  curvature  of  angularis  region. 
Divided   into  3  types  based  on  endoscopic  appearance 
1. Type I – protruding 
   2.    Type  II – superficial  
                       a -  elevated 
                       b -  flat 
                       c - depressed  
    3. Type III  -  excavating 
          Majority  of  early  gastric  cancer  are  well differentiated  tubular  or  papillary  variants 
II. late  gastric  carcinoma 
        Invasion  of   tumor  into  muscular  wall 
                                                                
                                      
 
 
TNM  CLASSIFICATION  OF  GASTRIC  TUMORS
81 
T – primary  tumor 
TX – primary  tumor  cannot  be  assessed 
T0 – no  evidence  of  primary  tumor 
Tis  -  Carcinoma  in  situ:  intraepithelial  tumor  without  invasion  of  lamina  propria 
T1 – Tumor  invades  lamina propria  or  submucosa 
T2 – Tumor  invades  muscularis  propria  or  subserosa 
T3 –Tumor  penetrates  serosa  [visceral  peritoneum] without  invasion  of  adjacent  organ 
T4 –Tumor  invades  adjacent  structures  such  as  spleen,  transverse  colon , liver, diaphragm, 
        Pancreas, adrenal, abdominal  wall, kidney, small intestine and  retroperitoneum.     
N – Regional  lymph node 
NX  -  regional  lymph  node  cannot  be  assessed 
NO – no regional  lymph  node  metastasis 
N1 – Metastasis  in  1- 6  regional  lymph  nodes 
N2 – Metastasis  in  7 – 15  regional lymph nodes 
N3 –Metastasis  in  more  than  15  regional  lymph  nodes. 
M – Distant metastasis 
MX – Distant  metastasis  cannot  be  assessed 
M0 – NO distant  metastasis   
M1 – Distant  metastasis 
    
        
 
STAGE  GROUPING
81 
Stage  0   -   Tis               N0               M0 
Stage I A –   T1               N0               M0 
Stage IB  -    T1               N1               M0 
                      T2               N0               M0                       
Stage II  -     T1                N2               M0 
                      T2               N1               M0 
                      T3               N0               M0 
Stage IIIA  -  T2               N2               M0 
         T3               N1               M0  
                      T4                N0               M0 
Stage IIIB  -  T3                N2               M0 
Stage  IV  -   T4                 N1,N2,N3   M0 
                      T1,T2,T3     N3                M0 
                      Any T          Any  N         Any M1 
 
 
 
 
 
 
 
 
BORRMANN   CLASSIFICATION
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Based  on  macroscopic  appearance  it  is  of  4  types 
   Type  I      -  polypoid  cancer, occurs  on  corpus  along  greater  curvature    
   Type  II    -  fungating  type, occurs  on  antrum  along lesser  curvature 
   Type  III  -  ulcerating  type, occurs  on  corpus  along  greater  curvature 
   Type  IV  - diffusely  infiltrating type  or linitus  plastica  , stomach  has     leather  bottle   
appearance  
    Type  II  and  III   are  more  common. Mucinous  adenocarcinoma  appears   gelatinous  and   
glistening   on  cut  surface. 
Based  on  degree  of  differentiation, it is  of  3  types 
1. well  differentiated   
>95%  of  tumor  composed  of  glands 
2. Moderately  differentiated 
                   50%  -  95%   of  tumor   composed    of  glands   
      3.  Poorly   differentiated       
                   <50%   of  tumor  composed  of  glands 
LAUREN   CLASSIFICATION 
                         1.  Intestinal  
                         2.  Diffuse                  
                         3.  Mixed 
 INTESTINAL  TYPE   
        This  type  has  features  resembling  differentiated  colonic  carcinoma, characterized  by   
recognizable  glands  that  range from  well  to  moderately  differentiated  with  more  
 inflammation.  This  type  of  tumor   arise   from   the  background  of  intestinal  metaplasia, 
can  also  be  associated  with  atrophic  gastritis  ,  dysplasia  in adjacent  mucosa. 
       Mucinous  phenotype  can  be   intestinal , gasric  or  gastrointestinal. 
DIFFUSE  TYPE  
         This  type  is  composed  of  poorly  cohesive  cells  diffusely  infiltrating  into  the  gastric 
  wall  with  little  or  no  gland  formation. Individual  cell  is  small,  round  , arranged  in  single  
 or  in  clusters. These  cells  can  also  be  arranged  in abortive,  lacy  gland  like  or  in  reticular  
 pattern. This  type  resembles  as  signet  ring  cell  tumor  in  WHO  classification.   
        It  has  low  mitosis  than  intestinal  tumor. There  will  be  small  interstitial  mucin, more   
desmoplasia  and  less  inflammation. 
WHO  classification  
        Adenocarcinoma – intestinal, diffuse 
        Papillary  adenocarcinoma 
        Tubular  adenocarcinoma 
        Mucinous   adenocarcinoma 
        Signet  ring  cell  carcinoma 
        Adenosquamous  carcinoma 
        Squamous  cell carcinoma 
        Small  cell  carcinoma 
        Undifferentiated  carcinoma 
        Others 
 
 
TUBULAR  ADENOCARCINOMA 
          It  is  composed  of  prominent  dilated   or  slit  like  and  branching  tubules  varying  
in their  diameter,    acinar   like  structures  are also  present. Individual  cells  are  columnar , 
cuboidal  or  flattened  by  intraluminal  mucin. Clear  cells  may  be  seen.   Cytologic   atypia  
varies  from  low  grade  to  high  grade. The  poorly  differentiated  variant  is  called  solid  
carcinoma. Tumor with  a prominent  lymphoid  stroma is  called  medullary  carcinoma or  
carcinoma  with  lymphoid  stroma. 
PAPILLARY  ADENOCARCINOMA 
       It  is  a  well  differentiated  exophytic   tumor  with  elongated  finger  like  process  lined  
by  cylindrical  or  cuboidal  cells  supported  by  fibrovascular  connective  tissue  cores.  The   
cells  maintain  their  polarity. Some  show  tubular  differentiation   [papillotubular]. There will  be  
severe  nuclear atypia. Tumor  edge  is  sharply  demarcated  from  the  surrounding  areas                                                                                
MUCINOUS  ADENOCARCINOMA 
        This  type  is  identified  by  the  presence  of  extracellular  mucin  which  constitutes   
>50%   0f  tumor  areas.   It  has  two  major  growth  patterns 
1.  glands  lined  by  a  columnar  mucous  secreting   epithelium  with  interstitial  mucin 
2. chains  or  irregular  clusters  of  malignant  cells  floating  freely  in  mucinous  lakes 
scattered  signet  ring  cells  are   also  present. 
SIGNET  RING  CELL CARCINOMA 
        >50%  of  tumor  consist  of  isolated  or  small  groups  of  malignant cells  containing  
intracytoplasmic  mucin.  Signet  ring cells  may  also  form  delicate  trabecular, glandular  or  solid  
pattern. Signet  ring cell  carcinoma  are  infiltrative  with  more  desmoplasia. special   stains  used  to  
express  the  mucin  are  PAS,  Alcian  blue  and  mucicarmine      
Tumor  cells  have  5  morphological  features
81 
1. Signet  ring  cells  -  cells  with  nuclei  pushed  against  cell  membrane  creating 
  classical  signet  ring   
appearance  due  to  an  expanded , globoid , optically  clear  cytoplasm. These  cells  contain   
acid  mucin  which  is  stained  by  alcian  blue  at pH  2.5 
2. Histiocytoid  - other  diffuse  cancer  contain  cells  with  central  nuclei  resembling  
 histiocytes   with  little  or  no  mucin 
3. Eosinophilic  - small  deeply  eosinophilic  cells  with  prominent  but  minute  cytoplasmic  
 granules  containing  neutral  mucin 
4.  Small  mucin  poor  cells  - small  cells  with  little  or  no  mucin 
5. Anaplastic  cells    with  little  or  no  mucin 
NEUROENDOCRINE   DIFFERENTIATION  IN   ADENOCARCINOMA
1 
       Can be  placed  in  one  of  the  following  category: 
1. well  differentiated   and  slow  growing  well  differentiated   neuroendocrine    tumors 
composed   of  neuroendocrine  cells  of  the  gastric  mucosa. 
2. Tumors  with  morphological  features  of  neuroendocrine   differentiation  such  as   
trabeculae,  rosettes,  insular,  dense  core  secretory  granules   ultrastructurally;  
immunoreactive  for  NSE (neuron specific enolase)  and  other  neuroendocrine  markers. 
   Tumors  with  features  of  large  cell neuroendocrine  carcinoma  of  lungs  have  worst 
prognosis   
3. Small  cell carcinoma  are  morphologically  analogous  to  pulmonary  counterpart  with 
aggressive  clinical  course. 
4. Other wise  typical  adenocarcionma  of  either  diffuse  or  intestinal  type   having   cells   
that  exhibit   argyrophilic  or  some  other  phenotypical   attribute   of   neuroendocrine  cells 
2
nd
  and  3
rd
   categories  are  common.                  
OTHER  RARE  VARIANTS 
ADENOSQUAMOUS  CARCINOMA 
          It  has  combined  expression  of  both  adenocarcinoma  and  squamous  cell carcinoma. 
If  there  is    a  distinct  boundary  between  the  two  components,  then  it  is  called  collision   
tumor. Tumor  with  discrete  foci  of  benign  appearing   squamous  metaplasia  are  termed    
adenocarcinoma   with   squamous  differentiation  [ adenoacanthoma] 
SQUAMOUS  CELL  CARCINOMA 
         Pure  squamous  cell  carcinoma  is  rare  in  stomach. It  resembles  squamous  cell  carcinoma 
arising  elsewhere  in  the  body. 
.UNDIFFERENTIATED  CARCINOMA 
         Belongs  to  intermediate  group  of  Laurens  classification  and  it  lacks  any  differentiated  
 features    
OTHER  RARE  TUMORS  IN  STOMACH 
         Mixed  adenocarcinoma  and  carcinoid 
Small  cell  carcinoma 
Parietal  cell  carcinoma 
Choriocarcinoma 
Endodermal  sinus  tumor 
Embryonal  cell  carcinoma 
Paneth  cell  rich  adenocarcinoma 
Hepatoid  adenocarcinoma          
   JAPANESE  CLASSIFICATION 
          Includes   2  categories  -  common  type  and  special  type  
    COMMON  TYPE   
          Include  papillary ,  tubular ,  mucinous  and  signet  ring  cell  carcinoma 
    SPECIAL   TYPE   
         Adenosquamous carcinoma, squamous  cell carcinoma  and  carcinoid 
Poorly  differentiated  can  be  solid  or  non  solid  type 
         In  addition  to  tumor  typing,  this  classification  includes  status  of  lymphatics,  venous 
penetration,  tumor  invasion, cancer  stroma  relation, pattern  of  tumor  growth,  hepatic,  
 peritoneal  metastasis  and  clinical / operative  features   
MING  CLASSIFICATION 
Based  on  tumor  growth  and  invasiveness ,  it  is  of  2  types 
1. Expanding  type 
This  type  has  growth  in  cohesive  nodules, fungating or polypoid  mass  with  sharply 
defined  periphery  compressing  the  neighboring   tissue . This  type  is  usually  associated  with 
chronic  atrophic  gastritis,  intestinal  metaplasia  and  dysplasia.  This  tumor  is  composed  of   
large  glands,  more  lymphocytic  infiltration  and  less  desmoplastic  response.  E cadherin  is  
preserved  in  this  tumor  which  is  a  cell  adhesion  molecule. On  electron  microscopy ,  well   
developed  desmosomes  are  present. This  type  constitutes  67%    of   gastric  tumor.   
2. Infiltrative  type   
This  type  has  indistinct  tumor  boundry.  It  shows  infiltration  by  individual  cell  or   
as  small  glands.  Cell  adhesion  molecule  E cadherin  is  lost.  On  electron  microscopy,  there  is  
loss   of  desmosomes. There  is  more  desmoplasia  than  that   of   expanding   type 
           This  classification  is  adapted   for  clinical  usage  and    image   analysis.  
Expanding  type  has  better  prognosis  than  infiltrative  type. Ming  and  Lauren   
classification  have  similarities.  Intestinal  type  are  similar  to  expanding  type 
Diffuse  type   are  similar  to  infiltrative  type.                                    
NAKAMURA’S  CLASSIFICATION 
1. Differentiated 
2. Undifferentiated    
Includes  poorly  differentiated  adenocarcinoma, signet  ring  cell  carcinoma, 
Mucinous   carcinoma 
MULLIGAN  CLASSIFICATION 
       On   the  basis  of    cell  type : 
1. Mucus  cell  type  (46.7%) 
2. Pylorocardiac  gland  cell  type  (29.7%) 
3. Intestinal  cell type (23.6%) 
GOSEKI’S  CLASSIFICATION 
     It  is  of  four  types  based  on  tubular  differentiation  and  amount  of   intracytoplasmic 
  mucin 
Group I   - well  tubular  differentiation  but  poor  mucin 
This  group  constitutes  around  40%  of  gastric  adenocarcinoma 
Group  II – well  tubular  differentiation  but  rich  mucin 
This  group  constitutes  around  3.5%  of  gastric  adenocarcinoma 
Group III – poor  tubular  differentiation  with  poor  mucin 
This  group  constitutes  around  20%  of  gastric  adenocarcinoma 
Group  IV – poor  tubular  differentiation  but  rich  mucin  
This  group  constitutes  around  36.5%  of  gastric  adenocarcinoma                                                               
Group I   is  more  prone  for  liver  metastasis  
Group III is  usually  an  intermediate  finding 
Group  IV  is  more  prone  for  lymph  node  metastasis,  peritoneal  dissemination  and   
direct  invasion  of  adjacent  organ. 
CARNEIRIO    CLASSIFICATION  
1. Glandular Pattern 
2. solid  pattern  -  better  prognosis  [according  to  WHO   it  has  poor  prognosis] 
3. isolated   
4. mixed  cell  type  
it  is  around  30%  of  gastric  adenocarcinoma  and  has  worse  prognosis 
ADACHI  CLASSIFICATION 
   On  the  basis  of  prognosis   
BETTER  PROGNOSIS  
Tubular adenocarcinoma 
Solid  /  medullary adenocarcinoma 
Well  differentiated  adenocarcinoma 
Mucinous  adenocarcinoma 
POOR  PROGNOSIS 
Signet  ring  cell  carcinoma 
Poorly  differentiated  schirrous  carcinoma 
Poorly  differentiated  mucinous  carcinoma 
JASS  CLASSIFICATION 
   Gastric  type   
   Intestinal  type 
FROM  VARIOUS  STUDIES 
 EXTREMELY  WELL  DIFFERENTIATED  ADENOCARCINOMA  STOMACH  [EWDA]   
        Takashi yao et al
75
  showed  that  Extremely  well  differentiated   adenocarcinoma [EWDA]  
is  a  neoplastic  condition  composed  of  highly differentiated  neoplastic  epithelium  which  
mimics  normal  gastric  mucosa  or  intestinal metaplastic  mucosa  with  mild  nuclear  atypia  
but  has  the  ability to  invade the gastric  wall. 
          EWDA  constitutes  1%  of  gastric  cancer,  mean  age [ 45-81yrs] 62 yrs, it  mimics  like  
neoplastic or   dysplastic  lesions  in  the  stomach. It  is  usually  located  in  the  upper  or  middle 
third  of  the  stomach and  it  also  has  both  gastric  and  intestinal  phenotype . Histologically 
too bland  and  too similar  to benign  foveolar  epithelium. This  tumor  is  similar  to  that  of  
adenoma  malignum  of  uterine  cervix. 
  MICROPAPILLARY  CARCINOMA 
        Dae  woon  eom  et al
14
, studied  a  rare  variant  of  gastric  cancer  called 
micropapillary  carcinoma[MPC]   identified  by  small clusters  of  tumor  cells  in  the   
clear  lacunar  space  mimicking  lymphatic or vascular channels.MPC   constitutes  6.4 %  of   
gastric  cancer. 
SPREAD  OF  GASTRIC  CANCER
81 
         Distal  carcinoma  of  stomach  invade  duodenum  in  high  percentage  of  cases.  
Carcinoma  of  proximal  stomach  involves  the  esophagus. The  serosal  spread  of  the 
tumor  is  more  common  in  infiltrative  type  of  gastric  cancer  than  expanding  type. 
Local  extension  also  occurs  in  the  omentum, colon,  pancreas  and  spleen. The  mucosal 
and  submucosal  - Borrman’s  lymphatic  plexus  of  the  stomach  is  often  invaded . From  here, 
the  tumor  spread to  perigastric, periaortic  and  celiac  axis  related  lymph  nodes. Distal  third  
involves  the  hepatoduodenal nodes.  The  mucosal  lymphangiectasia  associated  with  regional 
lymph  node  metastasis. Invasion of  tumor  into  blood  vessel  wall  is  called  vasculitis  
carcinomatosa. 
         The  most  frequent  site  of  distant  metastasis  are  liver, peritoneum, lungs, adrenal 
glands  and  ovary. Bilateral  metastasis  of  the  tumor  to  the   ovary  is  called  Krukenberg’s 
tumor.  Metastasis  also  occurs in uterine  body  and  cervix. 
PROGNOSIS
1 
   1.    Gastric  carcinoma  in  the  young  age   is  predominantly  of  diffuse  type and 
it  has  poor  prognosis.  
  2.    Tumor  stage  -  the  depth  of invasion  into  the  serosa  has  more  tendency  to 
spread  to lymph  node. This   type  has  poor  prognosis. 
         Shigang  ding M et al
69
, lymphatic  invasion  is  the source  of  lymph node  metastasis  in   
gastric cancer  extending  over  submucosal layer. It  has to be differentiated  by retraction   
artifact that isolate tumor aggregates  due  to  tissue  shrinkage  during  fixation.   
 3.    Tumor  in  cardia,fundus  or  esophago gastric  junction  has  poor  prognosis 
 4.    Tumor  with  expanding  or  pushing  margin  have   better  prognosis  than  that of  diffuse   
infiltration  type. 
5.    Small  tumor  size  is  associated  with  better  prognosis  since  they  are  associated  with 
depth  of  invasion. 
6. On the  basis  of  various  types, the  decreasing  order  of  prognosis is  that  of  
High  grade  carcinoma – adenosquamous, anaplastic  and  neeuroendocrine  carcinoma; 
diffuse  and  mixed;  glandular  pattern 
7. The   infiltration   of  inflammatory  cells  between  the  tumor  tissue has  good  prognosis.  
8. Tumor  with  perineural  invasion  has  poor  prognosis 
9. If  tumor  is  found  at  the  limit  of  excision, there  is  more  chance  of  reccurances  of  the  
tumor. 
10. Negative   lymph  node  status  has  5 years  survival  in  50%  of  cases . with  nodal   
involvement  the  survival  rate   decreases  to 10% . 
11. Radical  subtotal  gastrectomy  and  radical  lymph  adenectomy  has  better  survival  than 
other  types of  surgery. 
12. c-erB 2 protein  expression  is   an  independent  indicator  of  poor  prognosis.  
13. p53 expression  is associated  with  decreased  survival. 
14. Increased  expression  cathepsin D is  associated  with  decreased  survival. cathepsin B and 
cathepsin L expression  is  associated  with  tumor  invasion  and  metastasis. 
15. p27Kip 1 expression  is  associated  with  decreased  survival. 
16. Loss of  Fhit  protein  is  associated  with  decreased  survival.                                                                      
17.Expression of  T antigen  in MN  blood  system is  said  to  correlate  with  depth  of  invasion 
and  metastatic  spread. 
                 Shigang  ding M et al
69
  studied  that microvessel  density  is  a  prognostic  indicator  in  
a variety of  human  malignancies  with   increased   micro vessel  density  correlating  with  shorter  
overall  and  relapse  free  survival  rate. It  is  identified  by CD 105  +  associated  with  
blood vessel invasion and  distant metastasis  of  tumor.  Microvessel  is  regular  and  well 
formed  in  gastritis, dilated  and irregular  in  hyperplastic  polyp. In  gastric  cancer, 
 microvessel   is  irregular , dilated  and  immature. 
  MUCIN  PROFILE  IN  STOMACH 
        Gastric  mucins  are  critical  cytoprotective   proteins  synthesized  by  gastric  epithelial 
cells. Mucins  are  high  molecular  weight  glycoprotein  that  are   synthesized  by  secretory 
epithelial  cells  as membrane  bound  or  secreted  products
20
. 
       Mucins  are  characterized  by  a  tandem  repeat   region  rich  in  threonine /  serine which  
are  o-glycosylation sites. Each  mucin  is  distinct  due to  difference  in  tandem  repeat   
sequence  length and  has  unique  non  repetitive  sequence
67
. 
       In  general  mucins  are  classified  into  neutral  and  acid  mucin, of  which  acid  mucins  
are  of  2  types  - 1. sulphated  /  sulphomucin   2.carboxylated / sialomucin
67
  
       Normal  gastric  mucin  is  of  neutral  type. Small  amount  of  acid  mucins  such  as  sialomucin, 
sulphomucin  are  produced  in  foveola, neck  cells of  the  fundus,  foveola    of  antrum  and cardiac  
glands   of  stomach
73,67
. 
      Neutral  mucin  production  is  decreased  in  neoplastic  transformation  of  gastric   mucosa. 
The  transition  of  neutral  to  acid  mucin   occurs  in  intestinal  metaplasia  which  is  a  common   
precursor  condition   of  stomach  carcinoma
67
. The  mucin  that  is  produced  during  the  transition 
stage   and  gastric  adenocarcinoma   is  predominantly   of   sulphomucin, an  acid  mucin. 
      In  well  differentiated  adenocarcinoma,  it  is   predominently    of   sulphomucin  , which  is   
characteristic   of  mature   surface  mucin  cells. In  moderately   differentiated  adenocarcinoma  
and  poorly  differentiated  adenocarcinoma , there is  predominantly    sialomucin  
which  is  characteristic  of  intestinal  goblet  cells
20
.  
     In  mucinous  adenocarcinoma , the  mucin  secreted  is  acidic  mucin – o  acylated  form  of   
sialomucin. This  variant  has  good  prognosis  than  that  of  signet  ring  cell  
 carcinoma of stomach
18
, 
     Acid  mucin  and  neutral  mucin  are clearly identified  by   special  stain  studies   such  as  
PAS – periodic  acid  Schiff,  combined  alcian  blue pH 2.5 PAS.         
                  MUCIN  GENE  EXPRESSION  IN    NORMAL  GASTRIC  MUCOSA  AND    
                                                  GASTRIC  ADENOCARCINOMA  
          Human  gastric  epithelium  has  an  unique  mucin  gene  pattern  which  becomes   
markedly   altered  in  preneoplastic  and  neoplastic  conditions.  More  than  fifteen  mucin   
genes  have  been  identified.  They  are  categorized  into   
1. Membrane  associated  mucin   
MUC 1, MUC 3, MUC 4, MUC 12, MUC  16, MUC 17    
       2.   Gel  forming   mucin  
             MUC 2, MUC 5AC, MUC 5B, MUC 6   
              Gel  forming  mucin  gene  is  on  chr 11p15.5  
3.   Soluble  form    
              MUC 1N  -  MUC  7  
       In  normal  stomach  there  is  increased   expression  of   
MUC 1, MUC 5AC  in  surface  epithelium.  MUC 6  in  deep  gastric  glands.  MUC  2  is  not 
normally  expressed
20,62,67,73
. 
MUC 1
(73) 
        Expressed   in  apex  of  the  cell, It  has  inhibitory  role  in  cell  to  cell  adhesion, cell  to   
stromal  interaction and  cytotoxic  immunity. MUC 1  functions  as  signal  transducer  interacting   
with EGFR  and  participates  in  carcinogenesis.  It  is  a   marker  for  aggressiveness. 
 
MUC 2
73,67
 
       It  is  expressed in   intestinal  type  secretory  mucin  or  goblet  type  or  gel  forming mucin 
Normally  it  is  expressed  in  goblet  cells. It act  as  a  protective  barrier  and  has  tumor   
suppressor  properties.  It  is  responsible  for  the  indolent  behavior  of  the  tumor.  Since  it  is 
a  gel forming  mucin  it   act  as  a  containing  factor  preventing  the  spread  of  cells.  It  is  
commonly  expressed  in  intestinal  differentiation  of gastric  adenocarcinoma. It  shows  diffuse   
intracytoplasmic  positivity.  
Mucin 2 gene expression 
                       Takayuki seki  et al
76
,  studied  that MUC 2 a  glycoprotein  known as 
 intestinal  mucin related  protein  antigen ,expressed  in goblet cells including  
metaplasic cells  in stomach  other parts of  alimentary tract. 
                   Subramani  duraibabu et al
73
, studied  that  MUC5AC  and  MUC 6  are     
expressed  in  normal  stomach  mucosa.  MUC 2 is  not   expressed  in  normal  stomach  mucosa. 
             Samuel et al
67
  studied that  the process  of  neoplastic  transformation  in the  stomach   
is  associated  with decrease  in   expression  of  these  mucin  and  there is  increased  expression  of  
mucin  genes  such  as MUC2, MUC3 ,MUC4  which  is  normally  expressed  by  intestine.  
            Advanced   stage gastric cancer expresses  more   mucin  genes  compared  to  
 that  of  less  differentiated  and  early  stage of  gastric cancer.  He  studied  that   gastric   
cancer  frequently  demonstrate  3 types  of  alterations 
1. Loss of  normal  mucin  gene  expression 
2. Increased  mucin  core  peptide  immunoreactivity 
3. Expression  of  mucin  core  peptide and  mRNA  which  is  not  found  in  
 corresponding normal epithelium 
      The  transition  from  MUC 5  and  MUC6  mucin  gene  expression in  normal gastric  mucosa to 
MUC 2 and MUC3  mucin   gene in  intestinal metaplasia  is associated  with appearance  of  new  
carbohydrate  antigen. 
 Samuel  et  al
67
 studied  that  
1. Expression  of  multiple  mucin  secondarily  reflect   increased  dedifferentiation  and genetic 
      alteration  found in  advanced  gastric  cancer. 
2. Increased  mucin  gene  expression  may  contribute  to  tumor  cell  growth  and  metastatic 
abilities   
        Takayuki seki  et al
76
,   MUC 2, a sialomucin  which  is otherwise called  intestinal  mucin  
related protein  antigen. It is  a major colonic apomucin  expressed in  goblet  cells.    
Emmanuelle  leteurtre  et al
18
,   showed  that MUC 2 gene  is  located  on  chr11p15.5      
    Ackerman  et al
1
, showed  that MUC 2  gene  corresponds  to sialomucin  which  is  an  acid  
Mucin  not normally  expressed  in  normal  stomach. In this  study, 
         Minh d.nguyen et al
55
, studied  that   MUC 2 secretory  mucin gene  plays  first  line  defense 
  mechanism by protecting  epithelial surface   and  initiating  host  immune  response.                                                     
            Dabbs
13
 – since it  is a gel  forming  mucin, it  act  as a  containing  factor   preventing  the  
    spread  of  cells            
MUC 5AC
63 
       It is  otherwise  called  HGM  or  human  gastric  mucin. It  is  normally  expressed  in 
foveolar  epithelium  and  mucus  neck  cells  in  antrum, cardiac  and  fundus. It  is located  
 in  supra or  perinuclear  areas. 
 
 
MUC  6 
       It  is  normally  expressed  in cells  of  fundus ,glandular  cells  of  cardia, antrum, and  in  
duodenal brunner  glands. It  is  expressed  in  peri / supranuclear  area. 
MUC  3 
       It  is  not  normally  expressed  in  gastric  mucosa. It  is  expressed  in  adenocarcinoma   
of  stomach. It is  related  to  serosal  invasion,lymph  node  metastasis. It  acts  to  protect  the  
the  tumor  cell  from  adverse  physiochemical  condition  such  as  low  pH  and  involved  in  
cellular  adhesion. Its  expression  has  poor  prognosis. 
IN  NEOPLASTIC  TRANSFORMATION 
In  atrophic  gastritis  
      MUC 5AC  and  MUC 6  is  expressed  in  columnar  cells 
In incomplete   intestinal  metaplasia 
       Increased  expression  of  MUC 2  and  MUC 3. Decreased  expression  of  MUC5AC and  
MUC 6 in goblet  cells  and  columnar  cells. 
In  dysplasia 
      Decreased  expression  of  MUC5AC  and  MUC 6 than  intestinal  metaplasia. 
IN   GASTRIC ADENOCARCINOMA 
Early  gastric  cancer 
      There  is  a  small  expression  of  MUC 5 and  MUC 6. Its  expression  is  decreased   in  advanced  
cancerous  stage. 
In  gastric  type  
     Increased  expression  of  MUC 5AC  and  MUC 6  in  poorly  differentiated  carcinoma   
and   signet  ring  cell  carcinoma. They  have  increased  expression  of  MUC  3 and  
decreased   expression  of  MUC  2. 
In  intestinal  type  
       There   is    expression  of  MUC 2  and  CD 10                                                                              
Unclassified  type  
       All   MUC  proteins   are  negative  in  this  type. 
Mucinous  adenocarcinoma 
       There  is  increased  expression  of   MUC 2. Expression  of  multiple  mucin  core  peptides  
 in  gastric  carcinoma  is  associated  strongly with  increased  tumor  stage.  Increased  multiple 
 mucin  expression  reflect increased  dedifferentiation  and  genetic  alteration  found  in  advanced  
 carcinoma. It  also  contribute  to  tumor  cell  growth  and  metastatic  abilities
20,18
. 
ON  THE  BASIS  OF  MUCIN  HISTOCHEMISTRY
59 
Gastric  cancer  has  been  classified  into   
TYPE I     -  Gastric  type  [G  type]         -   MUC  5AC and MUC 6  positive 
                                                                         MUC 2 and CD10  negative 
 
TYPE  II   -  Intestinal  type [I type ]       -    MUC 2  and  CD 10 positive 
                                                                         MUC 5AC  and  MUC 6  negative 
TYPE  III  -  Gastrointestinal  type [GI]  -    mixed  type 
TYPE  IV  -  Null type  [N]  
TYPE  II   [Intestinal]  is  more  common  than  other  types 
 
 
 
 
 
 
 
Table   showing  Master  chart  with  subjective  assessment of  relative  proportion of acid  mucin  
 and  Neutral  mucin  in  gastrectomy cases. 
        
 S.NO    HPE  
   NO 
 AGE  SEX   REPORT  NEUTRAL 
  MUCIN  
 ACID  
MUCIN 
   1.  3393/08 48 M Moderately  differentiated   
adenocarcinoma 
       30%         70% 
   2. 3409/08 44 F Moderately  differentiated   
adenocarcinoma 
       20%      80%   
   3.    3428/08 35 F Moderately  differentiated   
adenocarcinoma 
       40%          60% 
   4. 116/09 35 M Poorly   differentiated   
adenocarcinoma 
       10%      90% 
   5.  438/09 50 F Moderately  differentiated   
adenocarcinoma 
       80%      20% 
   6. 498/09 60 M Moderately  differentiated   
adenocarcinoma 
       50%              50% 
   7. 655/09 49 F Poorly   differentiated   
adenocarcinoma 
       10%             90%  
   8. 780/09 29 F Poorly   differentiated   
adenocarcinoma 
       10%      90% 
   9. 932/09 57 F  Well  differentiated   
Adenocarcinoma with  
 neuroendocrine  differentiation 
 
  
        50% 
 
      50%     
    10. 2030/09 60 M Mucinous  
adenocarcinoma 
        20%          80% 
    11. 2060/09 55 M Early invasive adenocarcinoma 
stomach 
        60%          40% 
    12. 2195/09 40 M Well  differentiated   
Adenocarcinoma 
        20%       80% 
    13. 2472/09 64 M Well  differentiated   
Adenocarcinoma 
        10%       90% 
    14. 2783/09 48 M Poorly   differentiated   
adenocarcinoma 
        20%       80% 
    15. 3277/09 55 F Well  differentiated   
Adenocarcinoma 
        50%                50% 
   16. 3442/09 70 M Moderately  differentiated   
adenocarcinoma 
        10%       90% 
  S.NO    HPE   
   NO 
    AGE     SEX   REPORT  NEUTRAL 
MUCIN  
ACID  
MUCIN 
   17. 3515/09 55 M Moderately  differentiated   
adenocarcinoma 
    30%     70% 
   18. 950/10 55 M Moderately  differentiated   
adenocarcinoma 
    30%     70% 
   19. 1377/10 51 F Mucinous  
adenocarcinoma 
    10%     90% 
   20. 1982/10 65 M Poorly   differentiated   
adenocarcinoma 
    20%     80% 
   21. 2198/10 66 M Moderately  differentiated   
adenocarcinoma 
    30%     70% 
   22. 2308/10 55 M Poorly   differentiated   
adenocarcinoma 
    10%     90% 
   23. 2405/10 55 M Moderately  differentiated   
adenocarcinoma 
    30%     70% 
   24.  2433/10 50 F Moderately  differentiated   
adenocarcinoma 
    30%     70% 
   25. 2834/10 60 M Moderately  differentiated   
adenocarcinoma 
    40%     60% 
   26. 2951/10 60 F Squamous  cell  carcinoma                       - 
   27. 3157/10 52 M Poorly   differentiated   
adenocarcinoma 
    10%     90% 
   28. 3217/10 80 M Moderately  differentiated   
adenocarcinoma 
    10%     90% 
   29. 3355/10 48 M Moderately  differentiated   
adenocarcinoma 
    50%     50% 
   30. 3441/10 50 F Moderately  differentiated   
adenocarcinoma 
    60%     40% 
   31. 3583/10 47 M Signet  ring  cell  carcinoma PAS  -    Neutral  mucin 
   32. 3735/10 25 F Poorly   differentiated   
adenocarcinoma 
    30%     70% 
   33. 3737/10 65 F Poorly   differentiated   
adenocarcinoma 
    20%     80% 
   34. 4059/10 50 F Poorly   differentiated   
adenocarcinoma 
    30%     70% 
   35. 4335/10 58 M Moderately  differentiated   
adenocarcinoma 
    30%     70% 
  S.NO    HPE   
   NO 
    AGE     SEX   REPORT  NEUTRAL 
MUCIN  
ACID  
MUCIN 
   36. 4401/10 53 F Poorly   differentiated   
adenocarcinoma 
    10%     90% 
   37. 51/11 60 M Poorly   differentiated   
adenocarcinoma 
    30%     70% 
   38. 579/11 40 F Poorly   differentiated   
adenocarcinoma 
    10%     90% 
   39. 852/11 40 F Moderately  differentiated   
adenocarcinoma 
    30%     70% 
   40. 863/11 66 F Moderately  differentiated   
adenocarcinoma 
    40%     60% 
   41. 964/11 50 M Poorly   differentiated   
adenocarcinoma 
    10%     90% 
   42. 1121/11 61 F Moderately  differentiated   
adenocarcinoma 
    40%     60% 
   43. 1162/11 65 M Moderately  differentiated   
adenocarcinoma 
    10%     90% 
   44. 1175/11 60 F Poorly   differentiated   
adenocarcinoma 
    20%     80% 
   45. 1287/11 64 M Well  differentiated   
Adenocarcinoma 
    20%     80% 
   46. 1537/11 55 M Moderately  differentiated   
adenocarcinoma 
    10%     90% 
   47. 1826/11 50 M Well  differentiated   
Adenocarcinoma 
    10%     90% 
   48. 2160/11 58 M Moderately  differentiated   
adenocarcinoma 
    30%     70% 
   49. 2876/11 35 M Poorly   differentiated   
adenocarcinoma 
    10%     90% 
   50. 3129/11 48 F Poorly   differentiated   
adenocarcinoma 
    10%     90% 
                                                   
                   The  mucin  was  predominantly  acidic.                                
 
 
                                                    
 
                                    OBSERVATION  AND  RESULTS 
             During   the  period  October  2008  to  September 2011, a  total  of  13,593  cases  were  
 received, of  which  303  cases  were  from  gastric  biopsies  and  50  cases  were  gastrectomy  
specimens . 
  Table  1 ;   Gastric endoscopic  biopsies  results  of  male          
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Table 2;  From  gastric  endoscopic  biopsies, incidence of  gastric cancer  in  male   
 
Total endoscopic biopsies 
    
      Male  cases 
  
Gastric cancer 
 
                  303 
 
         230 
 
       111 
       
                    Among  the  biopsies in  males, most  of  them  were  carcinoma  111   (48.2%), 
it was around  36.6%  in  total  gastric endosopic  biopsies. The maximum  incidence   occurred   
 in  the 6
th
  decade (30.6%)  followed  by  7
th
  decade (28.8%)  and 5
th
  decade (26.1%).   
           Next  to  carcinoma, most  of  them  were  chronic  gastritis , followed  by  dysplasia.                                                               
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Table  3; Endoscopic  results of female –gastric  endoscopic  biopsy  from 
2008 oct  - 2011 sep 
  
CHRONIC 
GASTRITIS  
 
INTESTINAL 
METAPLASIA 
 
DYSPLASIA 
 
CARCINOMA 
 
NORMAL 
 
NIL 
TISSUE 
AGE 08 09 10 11 08 09 10 11 08 09 10 11 08 09 10 11 08 09 10 11 08 09 10 11 
21-30 - 2 4 - - - - - - - - - - - 1 - - - - - - - - - 
31-40 - 1 4 1 - - - - - - - - - - - - - - - - - - - - 
41-50 - 3 4 - - - - - 1 3 - - 2 4 5  - - - - - 2 - - 
51-60 1 2 5 - - - 1 - - 1 - - - 5 4 2 - - - - - 1 - - 
61-70 - - 1 1 - - - - - 1 1 - - 5 1 2 - - - - - 1 - - 
71 -80 - - - - - - - - - - - - - - 1 - - - - - - - - - 
?AGE - - - - - - - - - - - - - - - - - - - - - - - - 
 
 
 
                      
 
Table 4; From  gastric endoscopic  biopsies, incidence of  gastric cancer  in  female 
 
Total  gastric endoscopic 
 biopsies 
 
  Female  cases 
 
        Gastric  cancer 
 
      303 
 
        73 
 
        34 
 
Chart: 2 
 
          Of  the  total  gastric  biopsies  received  for  female, most  of the cases  were  gastric  
carcinoma 34 in 73 cases(46.6%) followed  by  chronic  gastritis and dysplasia. The  maximum 
incidence  of  gastric   carcinoma   occurred in  6
th
   and 5
th
 decade (32.3%) followed  by  7
th
  
decade .(23.5%) 
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       The  incidence  of  gastric   carcinoma  and  dysplasia  was  more  common  in   male  
 with ratio of 3:1,  followed  by  chronic  gastritis.    
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              In  Thanjavur  Medical College , during  the  period  October 2008  -  September 2011, 
a   total  of   13,593 specimens  were  received.  It  include  303   gastric   biopsies  and  
50  gastrectomy   specimens. 
     A  total  of    353  gastric  specimens  were  received  during  this  period,  of  which  195 
(55.25%)   cases  were  reported  as  gastric  cancer. 
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Table  5; incidence of  gastric cancer  among received  specimens. 
       
Period  of  study 
 
   Total   cases 
 
No.  of  malignancy 
 
  Gastric cancer 
 
2008 oct – 2011  sep 
     
      13,593 
 
       
   4424 
        
      195 
 
Percentage  of  cases 
32.5 % in received  
Cases 
4.4%  
In  overall  cancers 
 
  Chart:5 
 
       Among  13,593 cases  received , 4424 (32.5%)  cases  were  reported  as  malignancy. Of   
overall  malignancy, 316 (7.14%)  cases  were  gastrointestinal  cancer ,of them 195 (61.70%) cases   
were  gastric  cancer.                                                     
gastrointestinal 
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TOTAL  MALIGNANCY 
Table 6; The  distribution  of  cases  according  to  age  and  sex  is  shown 
 
                  AGE 
 
              MALE 
 
                 FEMALE 
 
                20-29 
 
                   - 
 
                      2 
 
                30-39 
 
                   2 
 
                      1 
 
                40-49 
 
                   5       
 
                      5 
 
                50-59       
 
                  11 
 
                     8    
  
                60-69 
 
                   9         
 
                     5 
 
                70-79 
 
                   1 
 
                     - 
 
                80-89 
 
                   1   
 
                     - 
Chart :6 
 
                    Out of  50  cases, 29  cases were  from  male and  21  cases  were  from  female, 
maximum  number  of  cases  were  seen  in  6
th
  decade  for  male  patients  and  
female  patients.                                                                           
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                                   HISTOLOGICAL  TYPING  OF  TUMOR 
Table 7;   According  to  WHO classification 
TYPES  OF  GASTRIC  
 CARCINOMA 
   
                  MALE 
 
                   FEMALE 
          TUBULAR                     27           19 
          MUCINOUS                     1                                         1          
          SIGNET  RING  CELL                     1 -  
          PAPILLARY -                          -        
          OTHERS                      -                             1 
Chart :7 
 
        Most of  the  tumors  were  tubular  carcinoma  around  92%. Pure  signet  ring  cell  
carcinoma fig ( ) was  around  2% and  mucinous  fig ( )was   around  4%. Squamous  cell  carcinoma   
was  around  2% .                                                                     
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 Table 8 ; According  to  Lauren’s  classification 
 
TYPES  OF  GASTRIC  CANCER 
 
                    MALE 
  
              FEMALE                                                                     
 
            INTESTINAL 
 
                     20 
 
                  10 
 
            DIFFUSE 
 
                      9 
                        
 
                  10 
Chart :8 
 
            Among  50  specimens, 49  cases  were  adenocarcinoma. Of  which,  62%  cases 
were  intestinal  type, 39%  were  of  diffuse  type. The  intestinal  type  showed  male  
 predominance, the  diffuse  type  was equal  in  both  sexes.      
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TABLE 9 ;AGE WISE  DISTRIBUTION OF  GASTRIC  TUMOR  
 [ LAUREN’S  CLASSIFICATION] 
          AGE   GROUP    INTESTINAL TYPE        DIFFUSE  TYPE 
              21  -  30                  -                   2 
              31  -   40                           3                   3 
              41  -   50                 7                   6 
               51  -  60                12                   7 
               61  -  70                     7                   1         
              >7O                     1                   - 
Chart: 9 
 
    In  contrast  to  intestinal  type,  diffuse  type  is  more  common  in  young  age  with 
 equal   incidence  in  both  high  risk  and  low  risk  geographic  areas  due  to  regulation  by   
genetic  factors          
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Table  10  ;     According  to  Japanese  society  for  gastric  carcinoma, 
  TYPES  OF  GASTRIC  CA                   MALE                         FEMALE 
    PAPILLARY                    0                     0 
    TUBULAR                   20                    10 
    POORLY   DIFFERENTIATED                    7                      9 
    MUCINOUS                    1                      1     
    SIGNET  RING  CELL                    1                      0    
    OTHERS                    0                         1 
 
Chart: 10 
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TABLE  11:  According  to  Nakamura’s  classification; 
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Table 12;  year wise  results  of  the  differentiated  and  undifferentiated carcinoma;  
 
                 YEAR 
 
DIFFERENTIATED 
  CARCINOMA 
 
UNDIFFERNTIATED   
CARCINOMA 
 
        OTHERS 
 
2008 OCT  - 2009 SEP 
 
                     11 
 
                      5 
 
              - 
 
2009 OCT – 2010 SEP 
 
                     11 
 
                      7 
 
              1 
 
2010 OCT – 2011 SEP 
 
                      8 
 
                      7 
 
               - 
Chart; 12 
 
          Of  the  50  gastrectomy  specimens, 49  cases  were  adenocarcinoma, one  case  was 
Squamous  cell carcinoma. Table 12, shows  most  of  them were  differentiated  adenocarcinoma                                                                      
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YEAR WISE RESULTS  OF DIFFERENTIATED 
AND  UNDIFFERENTIATED  CARCINOMA   
DIFFERENTIATED CARCINOMA UNDIFFERENTIATED CARCINOMA OTHERS 
Table 13; Distribution  of  early  and  advanced  gastric  cancer 
 
      Types  of  cancer 
 
          Early  cancer 
 
      Advanced  cancer 
 
      No. of  cancers 
  
                     1 
 
                   49 
       
                   Early   gastric  cancer  is invasive  adenocarcinoma  of  stomach  confined  tothe   mucosa  or   
submucosa   regardless  of  lymph node  metastasis. In   this  study 98%  of  cases  were  advanced  
cancer  fig (1,2,3) ,2%  were  early cancer. 
Table  14; On  the  basis  of  differentiation, 
 
      Differentiation 
 
 Well  differentiated 
Adenocarcinoma 
 Moderately 
differentiated 
adenocarcinoma 
Poorly 
differentiated 
adenocarcinoma 
 
   No.  of  cases   
 
                7 
 
              22                  
 
                 17 
 
       Of  50 cases , 14.2%  were well differentiated fig (8,9 ) ,44.8%  were  moderately differentiated,  
34.7%  were   poorly  differentiated  adenocarcinoma. fig (10,11 )  
 
 
 
 
 
 
 
 
 
 
               
               FIG 1 ;Ulcerative  growth  with  heaped  up  margin in  antropyloric region 
                                     Measuring  6x4cm  invading  upto serosa    
               
             FIG  2   ; Ulcerative  growth  in  the  antropyloric  region  M  5x3  cm   with  
adjacent ironed  out  mucosa  and   metastatic node ( arrow) 
                                                                                                                                                                                         
              
             FIG 3 ; Ulcerative  growth  in  the  antropyloric  region  M 6x3 cm  with  thickened   
wall and   adjacent  ironed  out  mucosa 
              
                                 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
                    
FIG 8 ; Well differentiated  adenocarcinoma  showing  tubular  glands  invading  into                            
Muscularis  propria                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
 
        FIG 9 ; Well  differentiated  adenocarcinoma  stained  with   AB  pH  2.5  PAS  
showing  tubular glands filled  with  neutral   mucin  in  magenta  color ( X 400) 
 FIG 10  ; Poorly  differentiated   adenocarcinoma  with   malignant  cells  in  diffuse    
pattern  H & E  X 400           
 
FIG 11  ; Poorly differentiated  adenocarcinoma  in AB  pH  2.5  PAS  showing                 
malignant cells with  acid  mucin in blue color  X 400 
 
 SPECIAL  STAIN  STUDY 
           Gastrectomy  cases  were  evaluated   for  mucin  histochemistry  by  using combined 
Alcian  Blue  pH2.5  PAS and  PAS [ Periodic acid Schiff  stain] .Acid   mucin  was  expressed  in 48 
cases [96%] including intestinal metaplasia fig (4,5,6,7) , Mucinous adenocarcinoma fig(12,13,14)  
              signet  ring  cell  carcinoma  was  stained  by  PAS  shows  neutral  mucin expression.fig 
(15,16,17,18 )                                                                   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
              
FIG 4 ; Intestinal   metaplasia  in  gastric  mucosa  showing  goblet  cells along with                                                                                
columnar cells,  H&E   X 100 
             
           FIG 5 ;  Intestinal  metaplasia  in gastric mucosa  H&E  X 400 
 
               
               FIG  6 ; Intestinal   metaplasia  exhibited  by  AB  pH  2.5  PAS ( scanner view) 
                
           FIG  7; Intestinal   metaplasia  exhibited  by  AB  pH  2.5  PAS  showing  goblet  cells 
with acid  mucin   in  blue color   X400 
 
 
 
 
 
  
FIG 12 ;  Mucinous adenocarcinoma  showing  malignant cells floating in   mucinous  pool. 
H&E  X100 
 
FIG 13 ; Mucinous adenocarcinoma  showing  malignant cells in mucinous pool H&E  
X400 
 
 
      
       
           
FIG 14  ; Mucinous  adenocarcinoma  showing  malignant cells  in  mucinous  pool   in                                                                                                                                                                                               
AB   pH  2.5  PAS   showing  acid  mucin   in  blue color  X 400 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
               
FIG  15; Signet  ring cell carcinoma showing diffusely  arranged  signet  ring  cells H&E x 
100 
 
FIG 16 ; Signet  ring cell  carcinoma showing  diffusely  arranged  signet  ring  cells  with   
cytoplasmic mucin  pushing the nuclei to periphery H&E x 400 
               
               FIG 17 ; Signet  ring cell carcinoma  in    PAS  X  100 
               
FIG 18  ; Signet  ring cell carcinoma  in    PAS stain (Periodic  acid  Schiff  stain)  showing  
neutral mucin  in diffusely  arranged  signet  ring  cells   X  400 
 
 
 
 
 
Table  15;   Immunohistochemical  analysis in gastric  carcinoma 
S.NO HPE .NO AGE/SEX REPORT IHC DONE EXPRESSION 
1. 2030/09 60/M Mucinous  adenocarcinoma  MUC 2        +++ 
2. 2783/09 48/M Poorly differentiated   
adenocarcinoma 
MUC 2     Negative 
3. 1377/10 51/F Mucinous  adenocarcinoma MUC 2         +++ 
4. 2834/10 60/M Moderately differentiated   
adenocarcinoma 
MUC 2 Intestinal 
metaplasia  + 
5. 2951/10 60/F Squamous  cell carcinoma AE1/AE3         + 
6. 3583/10 47/M Signet ring cell carcinoma MUC 2         ++ 
7. 4059/10 50/F Poorly differentiated   
adenocarcinoma 
MUC 2      Negative 
8. 1162/11 65/M Moderately differentiated   
adenocarcinoma 
MUC 2 Intestinal 
metaplasia  + 
9. 1287/11 64/M Well  differentiated   
adenocarcinoma 
MUC 2   Negative 
10. 1826/11 50/M Well   differentiated   
adenocarcinoma 
MUC 2 Intestinal 
metaplasia  + 
             
          For  MUC2 ,   the  control  was  small  intestinal goblet cells fig (23,24)    
           MUC 2   stained  the  perinuclear  zone  in  goblet  cells  of  intestinal metaplasia, fig (25,26 ) 
diffuse  cytoplasmic  staining  in malignant  cells  and  also  stained  >50%  of  extracellular  mucin in  
mucinous  adenocarcinoma. fig(31,32,33,34 ) 
  
 
 
           FIG  23; Intestinal  goblet  cells  expressing  MUC 2   positivity – control  X100   
 
   FIG 24  ;  Goblet cells  in intestinal epithelium expressing MUC 2  in perinuclear  zone  
x400 
  
           
          FIG 25 ; Gastric  mucosa  with  intestinal  metaplasia in  H&E  X 100 
          
FIG 26 ; Intestinal  metaplasia  showing  MUC 2 positivity  in perinuclear zone of goblet 
cells x400 
                 
 
 
 
  
            
        FIG  31 ; Mucinous adenocarcinoma  showing  malignant cells in mucinous pool  
H&E X100 
          
        FIG  32 ; Mucinous adenocarcinoma  showing  malignant cells in mucinous pool H&E 
X400 
              
FIG 33  ; Mucinous adenocarcinoma  showing  MUC 2 Positivity  in  extracellular 
mucinous  pool  X100 
                  
FIG 34(a,b) ; Mucinous adenocarcinoma  showing  MUC 2 Positivity  in  extracellular 
mucinous  pool X400 
 
 
 
  
        Subramani Duraibabu et al,
(73) 
 studied  expression  of  MUC 2  by  semiquantitative   
approach. 
        In it 100 cells in 5 different  fields  should be counted and the mean should be taken. 
Results : 
      Negative                                                                                           (-) 
      Few positive     (< 25%)                                                                   (+)   
      Well defined  area with positive cells  (25% -50%)                         ( ++) 
      Extensive area with  positive cells (59%-75%)                                ( +++) 
      Most cells  are stained (>75%)                                                         ( ++++) 
          k.kawaguchi et al , studied   in signet ring cell carcinoma staining  of  >10%  of  cancer  cells  
was  classified  as  positive expression. <10%  were  classified  as  negative  expression for MUC 2. 
Fig ( 35,36)         
           Samuel et  al
67
, MUC2  is  commonly  expressed  in  intestinal  type  of gastric  adenocarcinoma.  
Wang rongquan et al
79
,studied MUC2   expression is  seen  in  well  and  moderately  differentiated   
adenocarcinoma.  The  expression  is  decreased  in  poorly  differentiated  and   variable in  signet  ring  
cell  carcinoma. In this study, poorly  differentiated adenocarcinoma  showed negative expression for 
MUC 2 fig (29,30)  
         According  to  Liu Q etal
94
,  Nguyen etal
55
, connel  et al
95
,  MUC 2 expression   
in  gastric  adenocarcinoma  varied  from  0-50%  of  cases. In  this  study, intestinal type  of   
adenocarcinoma is  negative  for  MUC 2  expression.fig( 27,28 )          
        AE1/AE3   showed  diffuse  and  strong  cytoplasmic positivity  in   Squamous  cell  carcinoma.   
Fig (19,20,21,22 ) 
  
 
 
 
 
                
  FIG 27 ; Intestinal type  of  adenocarcinoma showing  tubular pattern  in H&E  X100 
                  
                  FIG 28 ; Negative  MUC 2 expression  in intestinal type of adenocarcinoma  
 
 
              
                FIG  29 ; Poorly differentiated  adenocarcinoma  in H&E  x 400 
             
            FIG 30 ; Negative MUC 2 expression  in poorly differentiated  adenocarcinoma 
                          
FIG 35 ; Signet  ring cell carcinoma with signet ring cells  H&E  X 400 
 
FIG 36 ; Signet  ring cell carcinoma with signet ring cells expressing  MUC 2 positivity 
    X 400 
 
                    
FIG 19 ;  Squamous  cell  carcinoma  with  malignant keratin  pearl in  H&E x100 
                 
                FIG 20  ; Squamous cell  carcinoma  showing  malignant cells  in  H&E x  400   
                 
            FIG  21 ; Squamous cell carcinoma expressing diffuse  cytoplasmic  positivity for  
AE1/AE3  X100 
                 
             FIG 22  ; Diffuse  cytoplasmic  positivity  of  AE1/AE3  in malignant squamous cells 
X400 
 
 
 
  
                                                                    DISCUSSION   
        Gastric  cancer  is  the  2
nd
  most  common  cancer  worldwide  constituting  50%  of  all  the  
gastrointestinal  cancer
46
.  It  is  more  common  in  low  socioeconomic  groups  and  60%   
occurs  in  developing  countries. Highest  incidence  is  in  East  Asia,  East  Europe and  some  
part  of  South  Africa  and  lowest  incidence  is  in  North America
65
. 
Table  16;   Comparison  of  sex wise  distribution  of  gastric  cancer  with  various  studies 
STUDIES         MALE          FEMALE       TOTAL 
Hidetsugu yamagishi et al
24         42          21          63 
Shigang  ding  et  al
69         41          10          51 
Lei  hung  et  al
42         38          11          49 
Jiangdong  wang  et al
60         47          15          62 
Kataya gudis  et  al
39         86          43         129 
Xiao  ping  et  al
83         40          17          57 
Young euncho et al
87         91          47         138 
j. maria D begnami et al
45         64           36         100 
Ok  jae lee et al
61         72          34         106 
Jiro nakamoto et al
31         78          30         108 
 IN THIS   STUDY         29                21           50 
       This   comparison   showed   that   there  was  male  predominance   in  gastric  cancer. 
From  above  data , the  common   M:F   was  4:1, in  this  study  M:F  was  3:2.  
 
 
    
Table  17;  comparison  of  mean  age  group,     
   
                        STUDIES           MEAN  AGE  WITH  AGE  RANGE 
Do  youn  park  et al
17                                 61yrs 
Leihung  et al
42                                61.6 ± 8 yrs 
Young  guncho  et  al
87                                59 yrs [ 23-84] 
Zhong  zheng zhao  et al
93                                61  yrs  [30-91] 
Ok  jae lee et al
61                                57.8 yrs 
In   this   study                                56.7 yrs[25 -  80] 
      
       Most  of  them  had  their  mean  age  as  61,59,57 yrs.  In  this  study, the  mean  age  was 
 56.7 yrs  for  both  male  and  female  patients         
              
 
 
 
 
 
 
 
 
 
     
           In  Thanjavur  Medical College , during  the  period  October 2008  -  September 2011 
a   total  of   13,593  specimens  were received. It   include   303  gastric  biopsies  and  
50   gastrectomy   specimens. 
               Among  total  specimens  received,    316  cases  were   reported  as  cancers  of  
 gastrointestinal  tract.    Of  which ,195  cases  were  reported  as  gastric  carcinomas 
Thus   percentage of  gastric  carcinoma    cases  among   gastrointestinal cancers  was 61.70%         
Table  18; 
Comparison   of  incidence  of  gastric  cancer  between  Thanjavur  Medical  College  and 
Sri  devaraj  urs  Medical  college, kolar,  Karnataka. 
 
Comparing   datas 
Sri devaraj  urs  medical 
College,kolar,Karnataka 
[Jan 1997 – Dec 2006]63 
  
Thanjavur  medical  college 
  [Oct 2008  - sep2011] 
Total  no  of  cases  received               19,615           13,593 
Total  malignancy               2744  (13.98%)            4424  (32.5%) 
Gastrointestinal 
Cancer 
                
                630  (22.96%) 
          
            316  (7.14%) 
Gastric  cancer                  305  (48.4%)            195  (61 .70%) 
Male  :  female                 1:0.5             3:2        
Commonest  decade           6
th
 and  7
th
 decade              6
th
 decade 
 
        R.kalyani  et al
63
  studied  that , In  sri  devaraj  urs  medical  college,kolar,karnataka, a   
total  of  19,615  cases  were  received  for  histopathological  examination  during  the  period   
                                                                    
Jan 1997 –Dec 2006. Of  them  2744 cases[13.98%]  were  malignancy. Of  the  malignancy 
630  cases [22.96%]  were  gastrointestinal  tract  malignancy.  Among  GI malignancy , the   
most  common  site  is  stomach.  Of  630  cases, 305  cases  were  stomach  cancer[48.4%].   
       In this study , 13,593 cases were  received  during  the  period  oct 2008-sep2011. Of them  
4424(32.5%) were reported as  malignancy.  Of  the  malignancy, 316(7.14%)  cases  were   
gastrointestinal malignancy. Of which 195 (61.70%) were  gastric  cancer.  
Table 19; 
  Comparison  of  age wise  and  sex  wise  distribution of  gastric  carcinoma in  gastrectomy specimens  
with  sri  Devaraj  urs  medical   college ,kolar,  karnataka. 
 
       AGE 
SRI  DEVARAJ URS MEDICAL  
COLLEGE [ JAN 1997- DEC2006]
63 
THANJAVUR  MEDICAL  COLLEGE 
 [OCT 2008 – SEP2011] 
       MALE    FEMALE      MALE      FEMALE 
     20-29          7         7          0           2 
     30-39        10         7           2           1 
     40-49        37        18           5           5 
     50-59        51        29          11           8 
     60-69        66        27            9           5 
     70-79        24         8           1           0 
     80-89         7         7           1           0 
    TOTAL       202       103          29          21 
  
           This  shows  that  gastric  cancer  was  predominantly  present  among  male  patients 
with  M:F  ratio  in  this  study  was  3:2, in  sri devaraj  urs  medical college  it  was  1:0.5  
The  peak  incidence  of  gastric  cancer  in  this  study  was  in  6
th
  decade  where as  in  
Sri  devaraj urs  medical  college  it  was  in  7
th
  and  6
th
  decade  and  40%  seen  between  
50-70 years.  
Table 20; 
Comparison   of  incidence
63
   of  gastric  cancer  among  total  cancers  with  other  areas. 
  AREAS           INCIDENCE 
BANGALORE           13.6% 
BHOPAL           5.8% 
CHENNAI          14.9% 
DELHI           3.9% 
MUMBAI              6% 
IN  OUR  STUDY           4.4% 
        
          From  the  registry, the  incidence  of  gastric  cancer  among  the  overall  malignancy  in 
Various  cities  during  the  period  1987 -  2003  were  shown  and  compared  with  the    
Incidence  of  the  same  in  our  institution  from  2008 OCT -2011 SEP. 
        Kamala  krishnaswamy  et  al
36
 studied  that  in  India  gastric  cancer  was  more  common  in  the 
southern  states  as  well as  in  Kashmir. Though  H.pylori  infection  was  an  important  risk  factor, 
salted  food  and  poor dietary  habits  can  also  inflict  damage. In  Tamilnadu, the  
 incidence  of  gastric  cancer  was  high  due to  high consumption of salt. 
                   In  Kashmir, intake  of  salted  tea  and  habit  of  consuming  sun dried  foods  
 which  promote nitrosocompound  formation. Intake  of  vegetables – Brassica ,spices  were  
 rich  source  of  nitroso compounds.   R. Kalyani  et al
63
,   studied  that  in India,  gastric  cancer  
 was  more  common  in  south  India  which  include Hyderabad,  Nellore,  Thiruvallur, Erode,   
Kasaragod, Palakkod,  Kancheepuram  and  south karnataka.   
                
Table 21; 
Comparison  with  types  by   Lauren’s classification ,  
        Studies   Intestinal  type  Diffuse  type   Total  cases 
Kabashima  et  al
4            40          20            60 
Shigang  ding  et  al
69            35          16            51 
Mikhail lisovsky et al
50            33           44            77 
Jaing dongwang et al
60            40             22            62 
Lei  hung  et al
42            32          17            49   
In  this  study            30          19               49 
              
         In  this  study,  of  50  cases,  49  cases  were  reported  as  adenocarinoma and  one  case 
was  reported  as  squamous  cell carcinoma. Of  which  intestinal  type  adenocarcinoma  constitutes 
61.22%  and  the diffuse  type  constitutes  38.78%.  This  shows  that   intestinal  type  was  more   
common  compared  to  diffuse  type. 
 
 
 
 
 
 Table22;  
comparison  of  cases  with  average  age  group  in  Lauren’s  classification 
              Studies  Average  age  - Diffuse Type Average  age – Intestinal type 
Kabashima  et  al
4 54.4  ±  9.1   55.5  ± 11.5 
 In  this  study  53.2     54 .3  
  
Thus  the  average  age  for  both  types  of  gastric  cancer  was  around  54 -55  years 
                                                                      
Table 23; 
 Comparison  of  localisation  of gastric  tumor 
 Studies  Cardia  Middle Antrum Total  cases 
Kataya gudis  MS et al
39      41     39      49       129 
Charles  M et  al
12      58      0      46       104 
Kabashima  et   al
4       3     34      28        60 
In  this  study     6      1       43        50 
   
          From the above  comparison, most  of  the  gastric  cancer  arised  from  antrum  of  the   
stomach,  followed by  cardia  and  fundus  region.  In  this   study, 86%  from  antrum,12%  from   
cardiac   region and  2%  from  middle  region  of  stomach. 
       Nubia munoz et al
58
, showed that  incidence  of  gastric cancer  at  gastric  cardia  was   
increased now  a days  and  It was  more  prevelant  in  canada, USA. Still  
 the  most  common  site  was  antrum  in our  study.  
 Table 24;    Comparison   of  gastric  tumors  by  differentiation 
 Studies  Well differentiated 
adenocarcinoma 
Moderately Differentiated  
adenocarcinoma 
Poorly  differentiated 
adenocarcinoma 
Total  
Cases 
Emmanuelle 
Leteurtre et al
18 
              2             11           18      31 
Shigang ding  
et al
69 
            19             22           10      51 
In this  study              7             22           17      46 
 
       From  the above  comparison,   most  of  the  tumors  were  moderately  differentiated, comprising 
around  44.8%  of  the  differentiated  carcinomas. Well  differentiated  constitutes  around  14.2%, 
poorly  differentiated  constitutes  around  36.4%  in  this  study. 
                                        
 
 
 
 
 
 
 
 
 
 Table 25; 
  Comparison  according  to  Japanese  society  classification, 
studies papillary tubular Poor Signet ring cell mucinous Total 
Hua chuan 
Zheng et al
26 
2 208 117 43 2 372 
Zhong sheng 
 Zhae et al
93 
16 226 100 65 29 436 
Min .a.kim 
Et al
51 
0 425 439 139 55 1058 
Min sung kim 
Et al
52 
0 94 105 38 11 248 
In  this  study 0 29 17 1 2 50 
  In  this  study  , one  case  was  reported  as   squamous  cell   
Carcinoma 
1 
 
               Thus  from  the above  comparison  most  of  the  cancers  were  tubular type  around 58% in 
this  study followed  by  poorly  differentiated  cancer  was 34%  and  the  signet  ring  cell  type  was   
2%.     
 
 
 
 
  
Table  26;Comparison  according  to  early  and  advanced cancer 
Studies Early cancer Advanced cancer           total 
Do youn park  et 
  Al
17 
86 56 142 
Yoo ri kim et 
Al
86 
2 27 29 
In  this study 1 48 50 
  
 Thus  98 %  0f  the  cancers  were  advanced  cancers 
                                                                             
Table 27; 
Comparison  among  differentiated  and  undifferentiated  carcinomas 
Studies Differentiated  undifferentiated total 
Hiroaki takahashi et al
25 89 13 102 
Jiro nakamoto et al
31 79 29 108 
In  this  study  31 19 50 
      
   From  above  comparison  most  of  them  were  differentiated  ( 62%)  and  the 
  undifferentiated  cancers  were  ( 38%) 
 
 
  
Table  28; 
Comparison  according  to  WHO classification. 
 
studies papillary tubular mucinous Signet ring 
 cell 
others Total 
cases 
Emmanuelle 
Leteurtre et al
18 
0 14 3 12 2 31 
In  this   
study 
0 46 2 1 1 50 
 
              This  shows  that  92%  of  the  cancer  were  from  tubular  type  , 4%  mucinous, 
2%   signet ring cell type and  2%  was  by  others. 
                                                                
        Nubia  munoz et al
58
,  studied  in  1990, stomach cancer  was  the  second  most  
 common  cancer  in  world  after  lung  cancer. About   800,000  (10%)  cases  were diagnosed.  
of  which  60%  were  in  developing  countries. Steady  decline  in  rates  have  been observed  
 everywhere  in  the  last  few  decades  but  the  absolute  number  of  new  cases  per  year  is  
 increasing  because  of  aging  of  the  population. The  overall  mortality  rate  is  around  70%-90%  
where  as  in  Japan it  is around  40%.  India  has  lowest risk of gastric cancer  (<15/100,000)     
                                                               
 
 SPECIAL  STAIN  STUDY 
      Gastrectomy  cases  were  evaluated   for  mucin  histochemistry  by  using combined 
 Alcian Blue  pH2.5  PAS  and  PAS [ Periodic acid Schiff  stain]. 
       Acid  mucin  was  expressed  in  48 cases [96%], signet  ring  cell  carcinoma  was  stained  by   
PAS  shows  neutral  mucin expression.                                                                   
IMMUNOHISTOCHEMISTRY 
MUC 2   IN INTESTINAL  METAPLASIA 
          Samuel b et al
67
 ,studied that in  intestinal metaplasia, MUC2  is  expressed  in supranuclear 
 region  of goblet cells due  to  compression of  cytoplasm by  mature  mucous  granules  in  goblet  
 cells. 
          In  this  study, MUC 2  was  expressed  in  supranuclear  region  of  goblet  cells  in  
 intestinal  metaplasia.  
MUC 2  IN  DIFFERENTIATED  GASTRIC ADENOCARCINOMA   
        Samuel et  al
67
,MUC2  is  commonly  expressed  in  intestinal  type  of gastric  adenocarcinoma 
.Wang rongquan et al
79
,studied MUC2   expression is  seen  in  well  and  moderately  differentiated  
adenocarcinoma. The  expression  is  decreased  in  poorly  differentiated  and   variable in signet ring  
cell  carcinoma. 
         According  to  Liu Q etal
94
,  Nguyen etal
55
, connel  et al
95
,  MUC 2 expression   
in  gastric  adenocarcinoma  varied  from  0-50%  of  cases. In  this  study, intestinal type  of   
adenocarcinomas  were  negative  for  MUC 2  expression.          
 
 
MUC 2   IN   MUCINOUS ADENOCARCINOMA  
     Celso . A et al
11
 ,  studied that MUC 2 expression  is more  in  mucinous  adenocarcinoma  of   
stomach. According  to  WHO, if  there is  > 50%  of  MUC2 expression then it  is  called  mucinous  
adenocarcinoma.MUC 2  is  expressed in  both  intracellular  and  extracellular  mucin. 
       In  this  study,  MUC 2 was  expressed  in >50%  of  mucinous area in  mucinous 
 adenocarcinoma.                                                                      
MUC 2   IN  SIGNET RING CELL CARCINOMA  OF  STOMACH 
     Meng meng tian et al
46
,studied MUC2  expression has  significantly  higher  lymph node   metastasis 
rate  and  vascular  invasion  than MUC 2 negative  signet ring cell  carcinoma  cases.MUC 2 expression   
also  increased in  those  signet ring cell  tumor having  deeper wall  invasion and higher TNM  stage.  
No significant  correlation was  found  between MUC 2 expression, age and distant  metastasis. Gastric  
signet ring cell carcinoma   expressing  intestinal   
phenotype markers (GI , I TYPE) has  significantly  lower  survival rates than those  without 
expression.      
      In  this study ,  signet  ring  cell  carcinoma  showed  positivity  for  MUC 2.  
MUC 2  - ROLE  IN  PROGNOSIS  OF  GASTRIC  ADENOCARCINOMA 
      Yusuki tajima et al
89
,  studied  that  MUC2  expression  indicates  mucosal  carcinoma  and 
  inversely  associated  with  submucosal invasion.   
       Kabhashima et al
4
 , studied that G – phenotype of gastric  carcinoma  can  potentially  degrade 
 the  extracellular   matrix   through   the   overexpression   of  matrix  metalloproteinase  compared 
with  intestinal type  of  gastric  adenocarcinoma.  Thus  gastric   phenotype has  poor prognosis than  
that  of  intestinal type. 
       Shibata et al
91
,reported  that  G phenotype  has  lower apoptotic index / proliferative  index  ratio  
than that of  I –phenotype of  gastric  cancer. He studied that gastric adenoma  associated  with  
 MUC 2 expression than  with advanced  cancer. I phenotype was  highly associated with  gastric 
 adenoma   than  early   and   advanced  gastric  cancer.  
           k.kawaguchi et al
35
, studied  gastric  phenotype cancer are  considered  to have  greater  
invasiveness and  metastastic  potential  than intestinal phenotype  of gastric  cancer.  
        Minh d.nguyen et al
55
, studied MUC 2 expression  is  variable  in   signet ring cell  carcinoma  of  
Stomach. 
        Jiro nakamoto et al
31
, G phenotypic  expression  in  submucosal  carcinoma  have an  important  
risk for lymph node  metastasis . For I  phenotype , it is  measured  by  proliferative  activity.  
       Ok jae lee et al
61
, studied  mucin phenotype  may  be  correlated  with histologic  differentiation   
and  Lauren’s classification of  tumor. It  was  quite  different  from  those  histological classification in  
many  cases.  Histologic  type  and  Laurens  classification  did not  have  prognostic  significance on 
multivariate  analysis.I phenotypic  expression  of  tumor was  an  
 independent  good prognostic factor   with  lower  tumor  stage. 
        Therefore  mucin  phenotype may have  an  important  role  as a prognostic  factor of gastric 
adenocarcinoma  compared to  conventional  histological types. I phenotype has better  outcome than  
non I type.    
SQUAMOUS  CELL CARCINOMA
13 
         Generally  squamous  cell  carcinoma  stain  diffusely  and strongly   with CAM 5.2, AE1/AE3, 
34bE12,  CK5/6,  CK14   and  CK19 
         In  this  study ,squamous  cell  carcinoma  was  stained  with AE1/AE3 which  
 show  strong  and  diffuse  cytoplasmic  positivity. 
 
          David  callacendo  Riva et al
15
 , studied  that  primary  gastric squamous  cell  carcinoma  is  
an  exceedingly  rare  disease  which  accounts  for  < 0.5%  of  all  primary  neoplasm  of  the 
stomach. since 1985 there  have  been  fewer  than  100  cases  published  in the  world  literature.  
Gastric  squamous  cell  carcinoma  occurs  mostly  in  male  with  M:F ratio  of  5:1 and  peak  
 incidence at 6
th
  decade  of  life    
      According  to  David  Callacendo  Riva  et al
15
, to  differentiate  pure  gastric  squamous  cell  
 carcinoma  from  extension  or  metastasis, 3 diagnostic  criteria  must  be  met, 
1. The  tumor  must  not  be  located   in  the  cardia 
2. The  tumor must  not  extend  into  esophagus 
3. There  should  be  no  evidence  of  squamous  cell  carcinoma  in  any  other  part  of  the body 
The  pathogenesis  for  squamous  cell carcinoma  of  the stomach  is  given  by 4 main  theories 
1. Nests  of  ectopic squamous  cells  in   gastric  mucosa 
2. Squamous  metaplasia  of  gastric  mucosa  before  malignant  transformation 
3. Squamous  differentiation  in  a preexisting   adenocarcinoma 
4. Multipotential  stem  cells in the gastric  mucosa   
Squamous  metaplasia  occurs  in  healing  gastric  ulcer and  a  variety   of  conditions  with  
 long  standing  chronic inflammation  such as  corrosive  gastric  acid  burns, chronic   
inflammation  in  Menetrier  disease, after  chemotherapy  for  well differentiated 
 lymphocytic lymphoma.                                                         
                                          SUMMARY  AND  CONCLUSION 
  From  the  period 2008 oct – 2011 sep, 50  cases  of  gastrectomy  specimens  were  analysed  
Age, sex and   site  of  the  lesion  were  recorded. Subtyping  of  carcinoma  was  done. Mucin  
 type   neutral / acidic  is identified  by  AB pH 2.5  PAS  and  PAS  staining 
 Immunohistochemistry   using  MUC2  primary  antibody   was  done  to  assess  the  role  of  
its  expression  in  various  types  of  gastric  adenocarcinoma. Results  were  tabulated  and  
analysed. 
From  endoscopic  biopsies 
 Incidence  of  gastric  cancer  among  gastric endoscopic  biopsies  - 47.8% 
 Gastric  cancer  in  male among  gastric endoscopic  biopsies  – 48.2% 
 Gastric  cancer  in female among  gastric endoscopic  biopsies  - 46.6% 
 Male  predominate  in  the  ratio  of 3:1 
 Male  peak  incidence in the 6th decade 
 Female  peak  incidence in  the 5th  decade  
From  gastrectomy  specimen 
 Incidence  of  gastric cancer  among  the  malignancies  during the  period 2008 oct – 2011 sep 
is  4.4%  
 Gastric  cancer  in  male  among   gastrectomy cases– 58% 
 Gastric  cancer  in female among gastrectomy cases - 42% 
 Male  predominate  in  the  ratio  of 3:2 
 Male  peak  incidence in the 6th decade 
 Female  peak  incidence in  the 5th  decade  
 Mean age of  gastric cancer – 56.7yrs(25-80) 
  Incidence  of  early  gastric  cancer  - 2% 
 Commonest  site -  antropyloric  region 86% 
 Intestinal type predominates  by 61.2%  with  male  predominance  
 Tubular  carcinoma  occur  frequently  about 92%  in  both  sexes 
 Incidence  of signet ring cell carcinoma – 2% 
 On  mucin  histochemistry, acid mucin  is demonstrated in - 96 % of   gastric  cancer.  
 Acid  mucin  is  expressed  more  in poorly  differentiated  and  mucinous  adenocarcinoma 
       type  of  gastric  cancer 
 MUC 2 expression  is  more in  intestinal metaplasia,   >50%  in  mucinous  adenocarcinoma, 
      >10%  in signet  ring  cell  carcinoma, absent  in  intestinal type  of  gastric  adenocarcinoma 
      and  poorly  differentiated  adenocarcinoma   
 AE1/AE3  showed   diffuse  and  strong  positivity  in  squamous  cell carcinoma. 
                  Though   endoscopic   facilities  and  immunohistochemical  studies  were  available, 
the   detection  rate   for  early  gastric cancer was  only  2%. This  emphasizes  the  need  for active  
screening  programs  for  early detection , management  and  preventing  the  progression to 
advanced  stage  of  gastric  cancer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                    APPENDIX  I 
                                                   HEMATOXYLIN  AND  EOSIN  STAIN 
Preparation of the solution : 
Harris hematoxylin: 
Distilled water - 1000ml 
Ammonium alum - 100g 
Haematoxylin - 5g 
Absolute ethyl alcohol - 50ml 
Mercuric Oxide - 2.5g 
100g of ammonium alum is dissolved in 1000ml of distilled water by heating and shaking at 
60°C. Add solution of 5g of haematoxylin in 50ml of ethyl alcohol and bring rapidly to boil. 
When it begins to boil, remove from flame and add 2.5g  of Mercuric oxide. Mix by swirling 
gently. 
EOSIN STAIN 
Eosin Y - 1g 
Distilled water - 20ml 
95% ethanol - 80ml 
Glacial acetic acid - 0.2ml 
Dissolve 1g eosin Y in 20ml  of water  add  95%  ethanol  and  glacial acetic acid. 
PROCEDURE 
 Sections to water. 
  Harris’s hematoxylin for 15 minutes. Rinse in tap water. 
  Differentiate  in  1% acid alcohol –  3 to 10 quick dips. 
  Wash in tap water very briefly. 
  Dip in ammonia water ( for  10-20 seconds ) saturated  lithium  carbonate until 
       sections are bright blue. 
  Wash in running tap water for 10-20 minutes. 
  Stain with eosin for 15 seconds to 2 minutes  depending  on  the  age of the 
       eosin and the depth of counter  stain required. 
  95% alcohol – 2 changes  Absolute alcohol – at least 2  changes. 
  Xylene – 2 changes.  Mount in DPX mountant. 
                                                                       
                                                                     APPENDIX  II 
                  COMBINED  ALCIAN  BLUE  pH 2.5   PERIODIC  ACID  SCHIFF 
   Preparation  of  stains 
   ALCIAN BLUE SOLUTION 
a)  Alcian  blue  - 1gm  
b) 3%  acetic  acid 
      c)    Schiffs reagent 
         Basic  fuchsin  1 gm,Sodium  metabisulphite, anhydrous 1 gm 
         Distilled water 200 ml, N/I hydrochloric acid 20 ml 
       Boil the distilled water; add basic fuchsin and stir, cool to 50° C. Then filter and add 
hydrochloric  acid, cool to  25°C and  add  the  sodium  metabisulphite. 
       This solution is ready for use when it becomes nearly colourless, which may take  up to two 
days in the dark. 
d)  1%   aqueous  periodic  acid 
METHOD 
 Dewax   sections  and  bring  to  water, flood  section  in  3% acetic acid  for 3mins  
 In  alcian  blue  solution – 5 min 
 Wash  in  distilled  water 
 1%  aqueous  periodic  acid  - 5 min 
 Rinse  well in  distilled water 
 Schiff’s  reagent  - 15 min 
 Wash in running  tap  water 5 -  10 min 
  Stain nuclei   with   Harris  hematoxyilin  and  differentiate   
 Wash  in  distilled  water 
 Rinse in  absolute  alcohol 
 Clear  in  xylene  and  mount  in  DPX.    
 RESULT;   ACID MUCIN – BLUE,  
                          NEUTRAL MUCIN - MAGENTA 
                                                 
                                                               
                                                              APPENDIX-III 
                                             PERIODIC ACID SCHIFF TECHNIQUE 
Solution required 
a) 0.5% periodic acid. 
b) Mayer’s haemalum 
c) Sulphurous acid 
Sodium  metabisulphite 10%  6 ml 
N/I hydrochloric acid 10%  5 ml 
Distilled water 100 ml 
(d). Schiffs  reagent 
Basic fuchsin 1 gm 
Sodium  metabisulphite,  anhydrous 1 gm 
Distilled water 200 ml 
N/I hydrochloric acid 20 ml 
Boil the distilled water;  add  basic  fuchsin and Stir, Cool to 50° C. 
Then filter and add   hydrochloric acid, cool  to  25°C and  add  the  sodium metabisulphite. 
This solution is ready for use when it becomes nearly colourless, which may take 
up to two days in the dark. (Alternatively activated charcoal may be added to the solution, 
shaken and filtered). The solution becomes  recoloured  it  should  be  discarded. 
Technique 
1)  Section to water 
2)  Periodic acid 0.5% 5 minutes 
3)  Rinse in distilled water 
4)  Schiff’s reagent 15 minutes 
5)  Rinse in the three fresh changes of sulphurous acid 
     2 minutes in each change 6 minutes 
6)  Wash in running tap each changes 5 minutes 
7)  Counter stain in Mayer’s haemalum 30 seconds 
8)  Wash in running tap water 5 minutes 
9)  Dehydrate, clear and mount 
Results Neutral  mucin  - Magenta,  Nucleus - faint grey 
                                                                    APPENDIX  IV 
                                                   IMMUNOHISTOCHEMISTRY  
Preparation of  gelatin coated slides: 
Chrome alum - 0.05 gm 
Gelatin - 0.3 gm 
Distilled water - 100 ml 
First chrome alum is added to distilled water and then the distilled water is heated to 
60◦C. Gelatin is added slowly to the heated distilled water. Glass slides are then dipped in this 
solution and dried overnight. 
Preparation of Tris Buffered Saline (TBS): 0.005 M TBS 
Distilled water - 10 litres 
Sodium Chloride - 80 g 
TRIS (Hydoxymethylamine) - 6.05 g 
1 M Hcl - 44 ml 
Final pH is adjusted to 7.6 with either 1 M Hcl or 0.2 M Tris solution 
Preparation of CITRATE buffer solution (antigen retrieval solution): 
Trisodium citrate - 2.94 gm 
1N Hcl - 5 ml 
Distilled Water - 1000 ml 
Final pH is adjusted to 6.0 with 1N Hcl. 
Antigen Retrieval: 
The slides are placed in citrate buffer in the coplin jar 
and capped. The jar is then heated in a 750 W domestic 
microwave oven for 15 minutes 
(5 minutes in low power(40), 5 minutes in medium power(60) 
and 5 minutes in full power(80) pausing only to top up the 
fluid. 
Procedure adopted for IHC 
1. Dewax the sections in xylene (1/2 hour, two changes) and bring sections to distilled 
water. 
2. Antigen retrieval using TBS by Microwave oven heating 
3. Cool to room temperature in running tap water for 20 minutes. 
4. Bring sections to TBS for 5 minutes. 
5. Drain and wipe off excess TBS around sections 
6. Incubate in endogenous peroxidase blocking reagent for 15-20 minutes 
7. Gently wash the slides in TBS for 5 minutes. 
8. Wipe off the excess fluid and Incubate in power block for 15-20 minutes. 
9. Wipe the excess fluid and incubate in Primary Antibody for 60 minutes 
10.Repeat steps 4 and 5 
11. Incubate in super enhancer for 30 minutes 
12.Repeat steps 4 and 5 
13. Incubate in secondary antibody  for 30 minutes 
14.Repeat steps 4 and 5 
15. Incubate in DAB (Diaminio Benzidine) substrate solution for 2-10 minutes 
(To prepare DAB substrate, add 1ml of Substrate buffer, 
1 drop of liquid DAB, and 1 drop of Substrate DAB). 
Wash in distilled water, counter stain with Haematoxylin, clear in xylene and mount with DPX. 
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